var title_f23_53_24400="Acute weakness in children";
var content_f23_53_24400=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Approach to acute onset of weakness",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 674px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Hyponatremia, hypernatremia, hypokalemia, hypocalcemia, and hypophosphatemia may all be associated with muscle weakness.",
"     <br>",
"      &Delta; Potassium may be high, low or normal in patients, and a family history is often present in patients with periodic paralysis.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Tsarouhas N, Decker JM. Weakness. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24400=[""].join("\n");
var outline_f23_53_24400=null;
var title_f23_53_24401="Benign metastasizing leiomyomas radiograph";
var content_f23_53_24401=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54918&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Benign metastasizing leiomyomas: Chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Benign metastasizing leiomyoma in the lungs. Arrow points to small nodules in the lungs.",
"    <br>",
"     (B) Benign metastasizing leiomyoma in right upper lobe (RUL); cavitation as a result of secondary infection is demonstrated.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Crapo JD, Glassroth J, Karlinsky JB, King TE, Jr. Baum's Textbook of Pulmonary Diseases, Seventh Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24401=[""].join("\n");
var outline_f23_53_24401=null;
var title_f23_53_24402="Megakaryocytes and platelets";
var content_f23_53_24402=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Platelets originate from bone marrow megakaryocytes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 237px; height: 481px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHhAO0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD39/vt9aSlbqaSvimjhAUg6UtFKwxDRS0VLiADNOU9M8e9NHtS5+uKLDTEPX3oJ9sUEc8UhJ5rJxSbKuBwykYyD601ExgDP508E+lAHPNHKIb84yc5H6/jTmbPI4PpS8gcUjAd+D3pa9AsKeQCpGaQHpxzSLu3sCQVPTsfpSsOcg5oaa1AcX3HgGkbAJxnJ7U1T2PSgdMr096pu6EhMdfWj+lKfekwM56Gs7DEzyev1o/SlPNIDyRjkU1EBRSdTQeBmlwcn0p2EGeaO1KKKpLuA3v6UtKfY0d6aVgDoKF9fWlpRW8USK/3m+tNpz/fb602m0AtJTgucZ6UhGGxSasFxKKKKLAFH40tIaVhgaQ0prn/ABB4ksdKhLS3lvEFbaWdx1/w461DTbGrvRK7OgoHoaz9H1KHUrRZo3Qr6q3WtHtj+VTYYp4I7mkKqBgYwKT8e1FFguRzxCRVGSMEMCDyCKepJVWHQ9aX6UqttyuQSe1FhCAc8k4x+VHpgUfWjqe1FtAEpT1ozRRYBDn60UYoosAUUUU7CCilop2ASlFFLVKN2AU+Jc5qNTlQcEexpyAnOBmtIrUQ5x+8P1puKlbhuvekC9jjFW0Tcaq/5NNI9alAOeTxTXUdRxzU2BMjpRkH3p23B6UEEMeOnWiw7jcEdRUc8ixRs7dB2qUgdq47xn4qtNHhzIRLKhGy3jy0jnpnaOcZpqNxpSk+WKu2dBNdia0fyt6Slfu4+b8Oxr5svr5by8u9Y1HzEn80rsZMADJXbwdp4UZQ8/Wt+81rXbnWpLjUb8x6csqSJb2rYAi8zYdoUllPU5Yjkg123w20Tw/4h0We8vbCG6vGud8glByMfcJGcEgZGevHNWl7K8nr6fketh4fU4upPV6bdCt8FtMbyLq7Xz47KR8RROMBSvBzwM5PP5V2/jvXpPDPhqbUoLZbu6aWO3trdn2CSWRwqgnsMnP4VvwxLEiomFVeK+fPiB9o1j4ntYePH1JfDtvOGsLa3jaOOSMDJlLqCWwc8D5uO1KlD21S8tt/+AcFWp7apKoz0r/hNL/TtVt9P13S7D7S6Zkh0/UBNOh27siEhWYYB6ZPHeuq0TW9M123efSL6C6RSVcIcPGR1DKeVIPYivF7vV5X8Tz+IbH4fXQgtgYLbXfs8xlRMbfMaEjc+BkZwTXFaff6Joeqajd6Dqt9Z+KLA77WeWNxFdp1dJkdQQGOckn071ssIpqy0f3/AKu35+Rir9UfVuPmx+lQywlp0eM7R3Pr6flk0/TLk3umWl2UMZnhSXaRypZQcYP1qdgFHOMdq4dUwauQO6JIiMyhnOFBP3jjtTsH/wDXTZoBMgDEg5BDL1H0/lQvmKG37ZB1UKMEe1CQm7C0UisGUHkZ7EYNLSsO4go70p9qKLAFJTYpI5QxidXCsVJU5wRwR9afT5QuFFVpL62iTfLPFFH2aVwgP0J60g1G0aATxzpLbn/lrGwdfpkVag30Ic0upapabGwkRXU/KwyKf6VSjYq9xBTo13ZptSwZ5waaWoh7AAk0Ac+1B6mkAqmQKOlIQe2M0uKDyKkYmASMj8KABkVBdTrbxeYwbaOuBnFZ+q+IdK0yKN7y8ijLHCp/Gf8AgPWiw4rmfKtybXpxa6XPKXEWFxuIPH5V8/2LDUri417VhNM9xEyhGtpFEWH2houhYDg9sEnmvWdX8T22qaVMmnQvOzwSMhdtuBjG44ywyCSOPSuPg06SLTbiCYmQy7XiijUSTKpUfKVOMZO3rycZPSqU1FM9PB0nC8prU5TWbdb+Gx+yWQEbARtKMOF2sAxZM5JzuPJ/Ouh8B6xZ+FNTHnLJOL5SJRA25YFLgRErgYXO4Zyfve1atx4B1VraU6cVieYozLdOGRVQ7gixnID5J+YnA9Kk1Pw7rdnGPKsI5tOlEk1zaebujE2AQ2FxkZGMAYzzjmm5px5eh2OrTqR5L6PzO7sNTwHN0SyuQQy8gDA9O1bEMwePdGx2k8YrxPR73VNFnRGEgjkkjaTT59pCFgQRHIOFy2NoPBx1rt9I8TWjXs1olyYbm3k2y2NyNkgzjlQeo9xUOCex49ahUw711j3X6na7mJzuP51DcWttcSLJc21tNIOA8kSswHsSKdBcJcKTG4bHUE8j2NTLgEY/M1i1YhO60AYJ65I6E0uMn0PelI7ZxSgYJ5PNIBjDB4/SmjsOPrUjfNnPTFJt+XPSmhMbtVgdwz26ZqGWJnX93I0bdiBkflVjt1HTrVbVdQtdL064vr2XyrW2QyyvtJCqOScDJq1q7Im1yYjAGTn6VBp95bajapc2UomgckLInRsEjI9RkHnv2rmta1qDX7W00vw7fRzHUwTJdW0gbybYY8x8joxyEHcM2f4TXTW9pb2ttDbWiCCCJVRFQYCqBgAfgKpx5VruNofHGke/y127m3H6nqaz9e1WHSNPub27VvsttA88zD0UZwPcnA/GtBiV6Ddz261yvxLtJNU8I6rYWrEXNxaOIhnblgQR/hVU/ekrkSaSPm/xpfat4hEGveKLN5NMv8i2W3l/dWSA8pt/vdCc8mmeC/FEvg7VUbQJri+hKOJ7ExlYpk3HOVOfmxyGHT6ZqnZStfaJeQNqskqW7iR7KcmPZgY43Hk5yMda0NEvRo/gPWpkuI9M1ptslu/mhZZIwdrLH3B+bkA8gV7/ACxS5LaG8naNn3tb+v0Pqrw5fW1/pUFxYuJLWaNZ4X9Y3G5fx5xWo3+feuT+E+nXGk/DvQba+Vlu1tlMqt1ViS2D+fTtXWnHTHOa8SqkptI546IZUkIBzkZqM47VLB/FUXsWOb7xoob7xppxkZpMgfTJS20+WAW7AnApc9s1FcCUgGNhkHoRnNK+oPY87+JniyXRdIWRFL3sknl2sMZJDyYP3h1IHUCvHdLnkbUjcXCp9skWQK8mW2NwfmBzzzgHgA4969U+K/hqbWorTU4UIvdP8xjEW+WWMrkjHc/LkV5HZzQ2+mqYJZo7ogxx8BRgk5B5ySTt5AAG0120kuXTc9XL+VUm1u9zvdG1aa2sds0odBuWTz/vy/L91lU4ALMwBHOBjvmvUvCXh5NKQXVwFe+lQEkxhREPQd8kHnJPpXl3w5H9o+LI7K+V18vYzNGTgyQjAHC4UHBJGeRivdSCTyvHrmuSceWQsZU5fdj13I7hlj5Y0zzMMRhhx6VyfxU1ibw94I1rVbUj7Vbw4gLDIV2O0N9RnjPevlvQ4NYS/EqXt9ZXeRKt688hK/KWGecEE9jwa2o4b2qbvY8+MW05XskfYGt6JaavZzxyQxiSaPYsoHIwcjkcjkdR0rzXXbS0kvFi1C1iT7KnlxvEd8qqGC8y7Ts2FiSSD1Bz1x6B8PNYm8QeCNH1W7hMM91AHde2emR7HGR9a868aC5T4nvaQ6i1sZbV5rdFmBRAVUSM0bEAMcHBPX8Oef2bUmux3YKpK7i2S6Ne6tZwXDaFqcN2kC/LbXshndCSFCmQbeOcnIPfGcYrrdK8Zx/bhpviGGPT9RWHzpGD/uo045ctgrknjt71zhup0uIraOKG2jSeFvIuImG2PG+SSRVzk5JySQAT3qvNZWs4k+1OdQV5v30s7mdwW3BowxIV4wCCFyRnjtUOV/iOl0KUulr9v6sevKCRkEc85HIpQvPNcP8ADvV5GSXSro7UtwPsbs2SY+m3k5OOMZA4IHau3VyTtYbXz+f0ocEtjy6keSbgOOOp6UzdlcqOMZGRinggjK4IPIOeDTSeDkED61JIw5GR1xzXFfGa4+y/C/xA2cAwCPrj7zqv9a2PGPiG38N6LLeXBYyMdkUSjLOx7D8Oa89uviPpt/Yy2/inRTDpLTqiNLKsiu6OG2uv3gVIUnIwfetqKakp2ukzanRqSXPGN0cp+z94E1pLyLxHc3dzpunMAY4Ebabxe24f3PqMntjrX0PTLWaO4tlmgYNG4BVl6YqQY9KrEV5V588jKUuZ3Yn41U8tbi6k82PKIu0bl4OepH6CrZBDZJ4xxRgLwKyRDVzhfGXww8O+KXSa9t5YrleDPayeU7jrhuMNg88iqnhb4UeG9BuI7qCye7vImBjuNRYTPHgfwgAKPrXotFbLEVEuW+gW05b6AOFAycUppKQMNxUEbhyR6Vncdhalixzn+dRVJEcZ4B+poW4D2+8aaSACaV+SfQHmmk54GPxpMgeDTSQCfTNJn8vXNNLE/SlcaRl69atdWc0asY3kiaNZFxlcjFfNOo6JLpGp/Y9XjSSeOFtl6ZCFmQEEAL0JGDkd/wAK+qGwVORn+dcl4j8K2Gr2Ew1K1jkj+8sZGTGQOGBHQ9a2p1nT9DfDVvYyaaumeb+BLmysPE9he3DmIQMINplx5SOvDsSQpTDYzjIPvmve2bng18v6taTaHd/Z7hxGZFKq7QZEyA5GecAZHA6Zr0rwF40Nppdva62xMSgRwyeYZHPJAycegGST6+lOrHTmTuehjMO6kVOGtvy8iD9o+01WXwP52ltObdblPt0UJOZIcHO7H8IbBNfPsNo0mlMBcSmOaMx20cTljPKSAsW0Hua+yY9V06fbDJcQq8q/6mYhSwPseo+mawIfCXgjwndvrCaVpem3GciduNpPHyA9D0+6K1w+LjThytHnR5orlsdD4ZimsvC+mx6iscNxFaoJlQYVCF5AHYCvIdO1eDxNqzeILvNtMpe2iliGYmVuU3ZU7SoVQc8ZJrp/HPjVbnSrzS9BF213cW8n777ORgfd2qGIJYkgcdAc+lc5aWcOn6RpYX+0rqOW3jWSzgt1FuSAQDPK23LAjLAnJIGOgrmb0belzswtF04XktXp8upqXh1JvE00E8t7PHexpEI0jVEjlKgSBZGAJjC8lsfNmqFrOgnubi1a2RGlliWKWFikAhjKqoHzAYOXJIH45qxd2og1bU9QXUJo74W2XsSsi2sUf/PRg+VXPYD1zWbYWH2D+0b5bKSW1jxFMlvMA0uAmNgZRhj/ABMpPfrWcbNf0jti1y28v6/4BHo5l0bx+selvbXkl0qyXpWJ/Nw67t7ZGGPfAwBnpxXqs+trplo39qMDEowWZgrHr69TmvLb641Oznsy+Y9Ws5QSvlfIQ65lkOBiRVDr34wTUPjDxLF4v8MWlnDEkGpLcB5kIyFVW42tzw2Qc4PPHFbKLna5x4jDyq1IyW3VnrfhTxPpPibTftei3ReFWMbRyDY6FTjkHmtsMrYVjhsZr5+8IaVc2+o288sF1p7sHgK2gLzvKDxJP8u1VOQeT0B5FdFpfjjxRbyRi/srbUYLaXyL7yFKywdDvwTluD0XOMdKmdNcz5X/AF+RlVwck/3eqOo+Leg3Gt6FGdP2C+tZPOhZ8jJHbjpkcZ7V5LFoGonVdTsoPDuqMLtDEZ55QIVZl+YiTqMH5s+2O9e76J4j0zWJlhsLrfIVLhcjkDGcZ57jt3qW6uLfS7RrnUvs0JA2yOp+UDPf0HNEajgrEUsRUorksY+nTp4P8EQPqszNBY26LJOxLZCqBkDrk+lafhXxDZ+JtLW/04uIGbaBIu1h9R2qnfw6X4y0mfTUuLaeLcBLGvzAp1xj34q74a0W20LT1srRVTq5QNu7+p5I+tRdNeZk1HlfNfmv8rGx0HT86T3o60UjMKXvzTR0poRRIzgfOwAJ+nT+ZoTAfRRRQAU5GxnjNNpV4zTQEjY3HnvzTDg/TNSN1PfnvTF+916UNkjicHnGKYee2DTyMnJNNbHSpuNIbjI+lQ3EojUADc7cBcZqb+ECkx3xzRcDznxj4S/4SFVw/kXMb71do+AO4Pt/XFc1oXg7xDpd3sjvLQW6sRHKjbiCQRnaR15/U17VUN5dW1lbvcXk8NvAgy8krhFUe5PArVVHy8i2N6eIq048ienoeT6jolzZjzJ75YbWKQGN4w+YcsPMLc8gjOcdKdqGiR3d/PDF9oaYjfb2qzKqzqCMupXOCBwoJAJyat6j8RdE1nXoNI8OpLqc5yZpo12wxoPvMWPX2wMEkDPNVbGc2UV1bPKPM86ZbeJoGlZEUeaGyBlQAXw3rgZFKrCdOzejO3C16k24y3Wv9f1/mX7i1lsI7i6lsXhhsoQ8MZ3G7d5G+d/NBLFsKOMYyBis95obeGxsNGUraNALi2trplLoEclj5ZyC+4k7mIA68nNJpkQt0vm0aVrWadFlmKbpvOi6BQc5LhT65DMSelW1e5nmtfKsdMtdQNs8NwbqcsbRtuQrIpOTt298ZOax9Tps4vX+tCldx6Tp9rNefY7i9HnhJzPcmbzdpDFTgj5lbB4BHocU3R4bzxBcKlq1xaCz2iSaCYrA2WYkuxBDfKxGxR15JBArm9bWW11BJpbmXUGvnMUTS5lij3YRk4wM+xyeTXaeN9Wg+H3gJp7LTkuorF0soIXJSMMzHLtjtnPA5rdRvZLVvYzxM/ZRVtW/6/r/AIBQf4c3V3dsbXxLDGrM8kccMRCorEFkGDypIH1AxWfqcN34G1Swv9T09SieastxaMY4ZgWLD5QcpgAcHg/Wus+G3imHxjYXgktLaHU7J1iuYbeTfG24ZWRD12kZ69x3rcu9Pg3RafqKGexucoquTmN+xB69M980pVJxfJU/r7jjhipxlaeqPIdT1O5uGsdSvib3SZiJSkMzxmYY2ssjHAAJ24xk8d625NXsJ9LuI7e0kbRp5D59up2+ZEVUqVmUgqA2/qCSQDXK6zdXNs15FKt1Z3CTCBs7DHIkZcbyAvAOAcH61a8P6VquqaZe3ttp5vIljbG8KkKyggABuC56dMg4HNdDprlTen9f1qehJq1+i/r+mbsEVleeHJH8NpHd3kkYOnWc6iCSKEDJLvk5dsjkkZPA6Zpvi3T9vh14mQC7uoEFxJKu1YiuQfMyzcEZwQCeBVfRtFkisZGu7DzHkt1jbzN+2JgMBmCjnAGDxkjjPOal+yrqeo+RrM015NbFE3w2a24+Zd77SASeQiBWwQPzrL4ZXvotf6/pGcZJvR3t/X9fqZWhwQ2utW0zSCLS55vlnE7J9o2KuERVA3c464PPermu6lPb+JryODXLi4vYpG8jG7GxV+ZBsIAAz7kdcnNS61o6yGys1jgkt9OhQXDyzhfKUNuZdjjO/cCMpx65qOLTtS8R3cdpZwyWhHmAz5D/ALo4PJxjHK8DnPequpPmbNbxT55dPyPUvh34in1/R0ku0UTwsYJGToWUDJ/WuqrnfAvh+PwzoUVhG7y7SWaSRdrSMTksR2JNdEaxm1f3Tw5NSk3Ha+noJn5gNpxjOaKWioENVtwPBHJHP1604ccdqo6lqtjpkUkl9cpEEUOQQSxBOBhRySTwAOSansrqC9tI7m0kEsEgyrAEfgQeQR3B6U0BPT4wDnIzTKdGM54z+NNASPnJ7Gmjrxz60jEFiCMEHOaZmpYrEgOc+v6U1mOMHmk3HqB+lN781I0L+lL24JxTc8U7tjn6UXGIfWvl/wDaF0+5/wCEul+zard6nEsX2mazJZxp4yAM4+VVORjvzz1BPv8A44utdh02K38L2ay6hdSeQLiRh5doMHMrA8nAHAAPOPoWeEPCVh4c0ma2Gby5uyXvrq4G57pz1LZ7cnA7Z75JPZhaqw79q9fL+ti4Pk1OB+Afg5dH8Hz6zfRlb3U03J6pAOVH/Aj83uNtR+J4WWS9tElNtBKhmWQzHc0+0hFA6YOOnTI5HOa9ekgzAIIgkUQXaAF4A9AO1eYePbWOESXFzJJMLdJDDaJwlzICNqvwcdDjpzx3rKdZ1qjm+pthan+0JvqY51BJL+4hf+0EUxCNLO1JKJcOu1yQuB1IOBkDv0FaskqjVJ30ttLurjykinuxbefEoSPDySOCMc4Bxnpn6cNcT77S0stR+3RX4kN48cz5kU7ukjKAEBG4YOeOeMii4a+u/LtLQmSLVFkZVs2CxInB2sBgDHzA7gM8c0/ZfI9dQ67dDQurY2ljDqSoss1rJ9ruHjBWNI/MJAEZAADAk9C2Bznt3XjuzOo/D3XobCxOqGSFpIIXXlifmVlA7jORXn51K51K0SzmgMFhb5QrjsAFDDAI3ELgMTxuNbvhfxVNplqU8mFrG3jj3zrPh4gzMVRg+MkdMAnH04pThNWl1TMsXQlVjGS3T/M8otJ9Xj0UzjSNfsmjtFtZtV/erLvz8qkDGUGANv0r2/4RX2q3fhO3GsJeJH9qDWjXzlp/IVBvdi3O3fuxntxWnL48sXh3m4VHJ2mN0YuCcDjtjJA471jx6trPjc3OmaXDLaQXBMdxesx+WPBBboO/AUficCtKuIlVi04W8zglhqs9ZLlS3bOf8JeHl8d+MdUvzdXLaZ9od3mjJVJIi2UjyMfP69Rwa96iggt7aKGCJI4YgFSNFwFA6ACs/wAK6FYeGdCttL02MLDAoDNj5pXx8zt6kmtQtgYHWuepU5nZbIjE11Udo/Ctv8yrqYCWc0igbguenIrwTxhqLXuoXi311JFZRxEs0u4QwnICrlASsjhgdzfSvfL0q1pMGGRsYc9+K+bPGGmrbz6nbXUszy3N2rpCZ2RZI9pJfaOGPRQO3WtMOk5al4GCc21vb9TV0mwgu76REZNPkY7JY/NLkIqEhQ7j5VfPOQc4/CrywX0N1b6kbC6g1O2t5JIxbuVb5mwGwuVKdOOhHYGsKD7PaCW4lthfxB4orgjzItu/DJEd3zBSQucj6HFXJmmEU1/Y3NzZTXAaZ47MkmYK/wC+VnJwNoxtA7Acda0knff+vz2PSd1r0PXvAvi2HxJYAHCahCMTxDIx6OAf4Tj+ldORjsfxrwLQbuXRPGOnXVxAsUstw8csUMTsRG+EV5DkqBxGeO9e+IyyIGQkg+oIrKpFLY8fE01Tqe7s9UKOTxRQetJWZgcz4nTTxrWnTXUet/a4x5sL6ejuhCNnDBcgnnoR0JrX0SKCOwD232orPI87tdIUlZ2OSWUgEfTA4xV+lp3HfSwmacnTim0ooT1ED/fP4imsSAdoBbHAJ4pz/fPrmm1m2MAe5H4UE5+tFFIBaM8UlFO4C/TrQelJRSuAcg8fhWHfaJaCwuXm3ySEFy2e/XgVuUyWJZV2uMqeq+v1pKVhON9TyRvBrvbzNpr3EInXyzMELP5fGVBPUe3vxVNPBSQJ5UUgaPYqMoUKJcdN2AORk817UAFQKo2qBgAcYHtVeGygh8sonKdCTzWyrSRssTiFZKZ49pXgnVo4Vgju2mhiVyoyw2llC5wDjtV2H4aS+VZI/mzJbAqI5XCqQTlgcdQf6Yr13AAGAKXH8qHXky3iq73l+hw2l+BLVLtnvreJ4wdy7nLkNnOV7Dnn8K7W0t4rOIxwII1POBzk+tP6UA8isnJvcylOc9Ztv1HFjz0waTuR0o75HBFIMe9K5FiO4iE8TISRn0rivGnhRNX08RSiPzAw2SGQxg46qSOx6V3IHOKa6q6lXAIPGDVxk4hG8ZKcd0fOE63vh6eSS90qRbYhXfbzC0nKr85XcygHPPvjjiqkVxolza2trpkF3dQ2kLwzyzuPLLH52SEDrwCfcnmvoK50ldyxxKDG3BLfwj+tTW+h2MSEC3jXJydqgZPY/WuhV1vbX1O9ZjL+TVeZ4novh3VPEuuWN41pc2OnC4N0zSRmMg7hhBkZcEAdQB9K9/j3BFD/AHsc4qL7LCAo8sZGMHvU1ROpzWOStWlWleStYAQeQQaKKKyuZCUtJS0kxhQuaTmnJnnpVReoWCT75+tJXQf2da5z5R/76P8AjR/Ztp/zyP8A323+Nek8or9197/yNfYyOeorof7Otf8Anl/48f8AGj+zbT/nl/48f8an+x6/dfe/8g9kznqK6D+zbXH+qP8A323+NL/Ztp/zy/8AHm/xo/sev3X3v/IPZM56gV0H9m2n/PI/99N/jR/Ztr/zy/8AHm/xo/sfEd197/yD2TMDuaB9a6D+zrX/AJ5H/vo/40f2da/88v8Ax4/40v7Gr9197/yH7JmAF4Ge/Sjv1rf/ALOtf+eZ/wC+j/jR/Z1r/wA8j/30f8af9j1+6+9/5B7JmFgngj/GkwM8Gt7+z7b/AJ5n/vo/40f2fbf88z/30f8AGj+x6/dfe/8AIPZs58ghiMcfnS8jtW//AGda/wDPM/8AfR/xo/s+2/55n/vo/wCNL+xsR3X3v/Ifs2YCjPtQOORW/wD2fbDpGf8Avs/40f2da/8APM/99n/Gj+x8R3X3v/IPZswscEcZzSbcgDHNbw061B/1Z/77b/GlGn2w6Rn/AL6P+NP+x8R3X3v/ACE6TMLbz0yaGXBHoK3P7Ptv+eZ/77b/ABpfsFt/zzP/AH2f8af9kV+6+9/5B7JmC3HX71M7V0H9n2uc+Wc/7x/xo/s+1/55/wDjx/xp/wBkV+6+9/5C9izn6K6D+zrXH+rP/fR/xo/s61/55f8Ajx/xo/siv3X3v/IPYs54+1LW/wD2ba/88j/32f8AGj+zbX/nkf8Avtv8aP7Ir9197/yD2LMClQZrf/s61/55f+PH/GgadajpGf8Avpv8aaymt3X3v/IFSZkGabP+ul/77NL503/PaT/vs1Gepo6mvIdSfdmF2SCab/ntL/32aXzps/62X/vs00UUe0n3ZWo/zpv+e0n/AH2aPOlx/rZP++zUZ45o7daPaT7sLknnS/8APWX/AL7NHnS/89pf++zURYA4Pf2pgmQuVycr146UuefdhzpdSx50v/PWX/vs0edL/wA9ZP8Avs1CJEPRlP0NIZoh1kXjg80+efdhzruT+dL/AM9ZP++zR50v/PWT/vs1UF5AWwJVJ9AaUXMbDKliOeiml7WXcfN5lrzpf+esn/fZo86X/nrJ/wB9moHlRE3McL61Et7btn96Bg4545o9pPuHNra5c86X/nrJ/wB9mjzpf+esv/fZqvHPFKzrFIjlDtYK2dp9D708EYo9pPuw5iTz5f8AntJ/32aPOl/56y/99mo9w9aSN0kBMbq46Hac0c8+7FzEvnS/89Zf++zSefLn/XS/99mopHVATI6KBydzAYrG1DxRo1lFI73yTmJtrx2im4dT1wVQEj8aFOb2bE5WN3z5v+esv/fZo8+b/ntL/wB9msLQ/E2k65NLBp90TdwoHltpo2hmjU9CUcA4OOtbAIIyDTc5xdm2LmfclE82P9dJ/wB9mk8+b/nrL/32aZSGpdSdt2F2SedN/wA9pf8Avs0efN/z2l/77NR9qWkqku7C7JPPm/57S/8AfZo8+b/ntL/32ajoqvaT7sLsk8+b/ntL/wB9mlE8v/PaX/vs1FSrVRqTvuxXYfxGnU0/eNLUMaF/Gg0ZzQaRRVv2uEiDW4i4cFt+fu98Y71UtpnNw+TuQDqWBwecj14wPzrU5xxVC+jR1BlBRhk+qn61VzCpHrc53XvFksGqnS9IFq93EV+0yXRYRwKylh90Ek4UnsOOSOMywaj4liaaaSxs9Ttym6OO3P2aVWz9072KnI5zkfrWRqng3S/EV6l+Lq70yV8RztayhluUGQFfcCO568/kK0n+GvhgySzWsF/ZXMgw01pqNxE5Prw+M8cnFap07f8AA/4IRjJ63HzeINd2wrbeG7eO4kJ2293qcUbsBjJG3cD1PftUGpePbXRrJ5td0jWLJknW3ZY7bz1LNwu1lOGz7c89Kxdc8K6zY3Fqthpdl4ktIJZHtjdyrBNbb+cM+PmUNzkfMe/IybreD/EOoW1g82vR6HcwRukkelxmRH34+YmQ8sABg9uTTSp9dvX/AIf8h2nfY6nTdU0zVrSC5sZ3mjnLhMEo2VOGBXggg8HPQ1eWBjCFhIVSdxyxYv8AUmsQeFFsfD0NjoN9cW19bsZYryZvNeSQsWbzc/eVyfmHHbGMDEVn420+3sLg+JJItHv7Jlju4Jn4DMcKyH+NG5IIHrnBBxHs+bWGv5lqEmrNnRQWxHM/lnByqqOB7896tEA0A5GQeKDWdxqKSsiA2dsX3mCIt0zt5pyW8SJsjQIuc4Xjn8Kpa3rVhosUb6hOEaUkRRKN0kpAyQijlsDk4rF8JeP9B8VBRp0t1DI+4xx3lu0BlAOCU3cOB3wTjvinySa5ktAfL1NjxDpr6toeo6fFcPBJdW7wrKM/IWUgHgg9+xFcPL4Fup41Emk+HY5zCqSyxtIu9gMZwoBGR716X7nik9acako7EygmeTXXw0vJFh+z2fhq2aHG1vJkmJwc4O/qO9Tx6f4z0+EG8h0OWaHiF7J5LTzAeMNtBAH1HavUaTaCMY4putN6PUXLG2iPNPBGjRWt5aanfzRm9s7WS2SOGWS4fY7AkPI4BbbjAGOBmu2OrxCJmRJ3OcbViJq69hasSfJRSTklRtP5isjXNMmt9N1C60aNZNRWCRoIpPuvJtO0fniocnN6i5Wti9p2oTXRAltzbk5+WRhuP4VbWcDhgwPuteF6bLpt5etI9vrGo6rdW0UH2tILn7THNjMobokIBwABgYBNd14b0LxZb6xYy3epyQ6XCZDcQXFz9qknyPkw20bMHrya0nQUd2Lmk3ax3+4YzkUoOeRUccKJt4yR0J5NS1gi1fqFFFFOwwpV70lOUZqo7iEP3jRQ3WkoY7ijvRnrRR/OkFwoIBXBANFL/OmBVls4nU4QAkYzjr9fWmpKbeXy5tqxOQIiOmcdPb2qnH4n0KTWY9Ij1nT31OUEx2qzqXfGc4Hc8Hj2rUlhSZGjlUOjdVahxaJ5eqJDjPbP1pMVwXjM3ltd6TYafdrBLf3bQPcSuAYI1iZ22sc/OQuASDg844rL+G/i66k1a90zUru+urSOA3Mc2oweTPABKYykhwA38Lbv9o1apNx5kCnr7yPUhXi/x0+G+v8Aiy9j1XSbyO6W3i2Jp7gIyjqSjdGJPY4+vavaEIYAggg9xS9qrD15YefPDc2jLld0ebfBDxHd6l4dfRdcilg1zR9sE0U6lXMePkYg89Bj8M969IrP1VUjV7qGBWvUiZVdYwZAvXAPpkA49qj8P6iNSt5Gzl4mMbfUdaVWcak3KKtcUnd3SPLvidFBN41vf7Wm1aCK1s7W8sV0p8XVwyySK8cYwfkyVLEYx8pNc94/1iHxL4n8GXtsmo6R4ih2yWGmSkSOz+aP9ZGvCoUBYsSCQCMcV7d4n8N6L4mtFtteskuY0J2NuaORM9drqQwz3wee9YPgjwz4d0rV7u60XS5UuIVFo17du8srKAMKrOT8oGBx6VvTrxjHZ3X/AA3/AA+hDWt7nbHnnuaO1H0xSj61xlDaSlzikNIkr393DYWctzdPshiG52xnAp1pcw3ltHPbuJIZFDIw6EGnXESTwtHIqsrcEMMg02CJoiFUqY8cDpimJsmJNFFFFguFFFFNALRSUtMApyd6bTkHWqihoaepoFKRyaAKmwWEpTjFKBxR3oHYbz1rkPirra6L4RkQSpBPqUyadDK7sixtLkbiyglcDPOODir914u0q01ldMuJWS4bBHyEjk4HIGOaz/itora14SHk2bX8thdwX4tFGTOsbgugHclC2B64rakkprmFa69TwbxV4fsvBPhjRNHuFnl8WzPJPpVzCyhrUs4xFuGNzeZt+bj7xwcZFfUlktytlbi/KG8ESCcp90ybRux7ZzXg3hq2upl0rwp4Nkvriy/tL+0NQ1C+sGjFrAHDNbZkGfMyBwP8TX0A5G4nHJOa2xc72T31/ry9Ahfl1OT+I2m6Rqmirb61JdxsZA1s1krPcJKOVeJVBJZeT06ZzxXNeHtL0aeO6tNN1OfWrx2jOprqbE3nkqcrEUYAqn8+eTXVeMtBm1Vra8tFWS6toZ4BC0zQ70lChtsi8o42jDYI68dxy2tabqN2bAahoOpQNaBJbTULK4jmuIWVsmKTaMmI8DI3EjOR65Q1jy3C7TukdFpGqT2c0tlOJpHjwUMoA85PVcdSOhzjmutjZXQMpyCOK8mm8TPptzYWmt21w91ODNJmIR3MRH8Rj4WRP9uMj3HWu68M6xDf6fbz2d5b31pOxaOeJiMoeny4yDngg9PwrOUJLVoiDUdtvyNi8tTOAUcK+NpyMgjuCK4TWvEFvowuo9OSLz0cCQRYRFGMbmPYAA9fSur8W6idN0aZ4mUTvhEz79T+AzXmAFqI4XCsDcKrK5+8+QDkZ4bPJAxzUq3U6qWHVR8z2JdIvdcWGK6vtVdby4YyGK5J8pF3HHyr8yqR7k9K6rQbzWZVnW7vrOWZXAIslym7+6c5wSMH8axdKnm1KPyNMsHvLWRdkroojjjyT8vOPuleg9fwrqPCGhHR7ZIltxbFjvdEO4AgYHP0xT3d2PEtJNJJO/RL+kdHbmXb++B3e+KmzTsVXvbq3sbOe6vZo4LaBDJLLI2FRQMkk1NrnOo8qsSk9aQ1xNl4h1HxN5R02VdJ0+7YrazvF5lzKu3cH2NxHkDI3AkjnAPFUbqPW9Lvb82er3kl/HEbi2sr+4jdLmNCFZmAQbFJwcqQeRx2qvZvZkuSPQpBlDziq0ZfzQqkjI6kcGnaXepqek2l9ArLHdQpMisMEBgCAfzqONxHMjyAruyozzikkRPdF1RgAE5NLRRSsaCUUtJSAWiiiqAKcnem0+PvTjuNCdzRnjrSHqaXrSGmFIaCQO+Kqz30EI+aQEnoBRYTklucH4k8EXGseIoLgySR2qzJI4jfZuCcjke+Pyr0UcAD0rlb/wAWRJctb2g8xtud4UkKfTp/nFYt54k1NlzHPBCoKs0hB27QckHpgkZGen1q229GVFVJpLotrncvqtmtyltJcos7E4RjgnHWrn415R4huLm/WWDUprX7N5u2SdUMbhVIO4OG4wQD64FSt4gv9H1BrCCddQggISW6VsKv7rf8oySxzgY759iKm19jZYeco3Tuz02eUpEXjAcA4ODVa31azlTd5ypxkhyARXnOo+LLuKwila6t7SAkLM21I8lmPzDc2MdyfWuJ1PVH16aSPw9Zapqdz5QxLBGWilLZ/wBYzEKuCx6Z6CrhTc9hKg071JKKPZ/Fd94am08Jr8VtewZ+SN4vNOTx8uBkfUYrj21vw9YaZb2Gg+HJZI1kZ4Y3lMWxs54bJYA+grh5LrXRqM0MenWWnahNGDJYvHI+/LKrFpIwyoc4x8x/AV0M91bazYv/AGPYz2c0Ia1ube8ZXdJtzBwzDJ+XaMEcEEHsKtwlBa7GtCNKT+K7+7/g/cy5Pqd9qM0l5fMHQzOkS+Xt27c5CgnJHy9SBnn2NWPD2jjxBr8vnOx0+A5aNcgbgxx8wJ6gDvz144qfxBGumaBb2Czx2U93uu8IoM0QwFbB5U5HB4P3vxrf+GMa2+jyRMVe4D/O+cs2AFBJwMjAGD6YrFdzapNU6fu6dDIm1C71vxNr+jwQNZabo8kUFmVnMEd1OU3PuZTuO3K/IOO568UPh94fvIvGMmpaY1xHoiPOssksh23LYCqIhuOY85bcR16Zyah8eaE2leNotXGgXerabeTJcma0iM8thdgKjP5Y5KPGq5wDgr716P4R8/8A4RnTRdWbWMiwhRbPjdEgztU44B24yO3Suib5Y+7s1/X9f8A8zk99yZaudShtllaVZQkf3n2HAGM5+lcp4puYfFWiLaaZf2kW26hkkWdyokVXDFDxxkD3rqGZopEhG6aJmbeJQcjJyNpxggdMen6tuYLXcPnki+YYKjIz09CK5U3F3NdGrLU4G30vxBJue31ayhntQHtRCGmUER7QZJXOXGCew5P5V9Du7jxTqUlh4i13TdRUwnfZ6UjRNNEGwCxJJKZznYcHue1ddrtsLrw9qmnafJdXF41s6ZB2H51YcNwueSR7gdK5rwZ4Z1fT9V0G61a3s4LTQdPa3t0il86WWSUDeSzY2KoGAgz16nFbQneLbf5ByKK1St/X9bHYab4hsbi9ksbWeylNuwikS1lD/Zz0CsOMdCOOmMGqfie8ls7uDyxKUJZ2KjIAGOMdyT/Wqmg+HbHw7f6lq092GEzMqFowpjRm3bTgncc9+OAOM5NZviK8TVNQDRqoijXyxKcsTkgnCjr90g5xjmspWTstiqcPaSWmh1umXnm+SGk5foOpJrYrA8IW0ttpXmXqssjOzpvxkIenfitZrxN4WP5z9cU9zmklSbTZZorObVYxkLG7OOMDsfemtqTS5jt0YS9DvRjt96GrbhGSk7Ik1XVrPS1j+1ykPLkRxqpZnwCTgDnoDVi2uFuEDx8qRnI6fnXProFxc309xJeXNuJ0WOcKVJkUZ4BxlevbFdJDEkMKRQqEjQBVUDAAFGlimmmPp6d6ZT4+9OO41uNPU0CkPU0tSwGyRpINsgDDryK8z+JU5i04wvHI7K3mhfN8pTt/2s8DJ9+vPSvTq82+I1k9zqUVxFLDFJFBIsYljDgsWU+uccdORzyOKum7MIRXtIs5RFhsjayy2MMd7KBCUZSAoD42ggfdzk84B7daumCZL79/cSrbo5UJAFYlcAgkHt94ceoPWqjqtrLHbyC8gDxshu1PybM7hE0pzjaTuBA74qlDJbXevTw2dykkkVv5LS+bmBoyxK7CpyWcry3GQvUGtN9TvWup0kjQ+dvZ/vlisJjyOOOBzjG7PTApviPxKdN0Gawn0yGC1trZnuUEuwyPg4UMQMBjnvnHSuStdYvkv7jStJ0e81CGKPy2PmFioJ5YsTknoSBzntV3Q9G0PSNFtte8ZaVea7qF3I6WdrFCbzyI0HAUdN3GSx5yauNDrL/gmVStCn1uy3a+CLnWfD738aW1zr/mlIrjUU2wwkAAmCPBXbkY3MCWwT3rrvhikOl2Miatrcmpa3JMbGSR42hjJjBYQxIeCFDH5sZYew4yNQ1LWvCUJ+x3Ud1p9t9lcQXsQ8y3hd9m4qp3IqjILMONpPPStPxJqPhdPEkj6rrmmW0kTj7OIdQwXk2nd5kYOMjp3yDVybkuXp0sec5yleT1ZUtdd0ldWTQRq2qyaotncLHdTzFAwlLMrMBx8jLsUnBGPxrlNE1PULvR7/VL+2lt57y+W2vHihUss4WOPfFu53ApyDxyat2V94b07xKL60u764uNiNM+k6Y84lUAHZvOQu7GSF5OTzUvhWxlvPh3qN/aagtrcwahcXj2rRrFMGMzSKjt95Hww4HfjmipFRhtvY6MHdyuRXKx60i2r3TzwW7b5RFb/ICHBij3kk5XaRtUY45NN0zxNc6Dc6k6JDFHHAgiSKPM0u3qAhGQEBxjPXNZaWdzJq8lzfRbbeVVCM/yyRgo7HO5htc42ljwT9DVnMtzLcQW6A3Ulq/lLOphiLFH3AyBuG64wT90npWSituh6PMmmnqj0Cy+JNqJp4dSh8iS2nNvLtbd82Awx+DAH39q3bLxrol3DNLHdfu4CwmbaSIiM5346dD1rx+2uPMvr62up45CYkka0uU2okRUZ2SMOAeBtP3yfxrRubR7+5lsGsGNuJP32zCGWExbklXHKjd1zz07VDpozdGn10/rzPZLXWtNuolkt763kQgEESDkEDH55FRS+IdIilkifULfzo13tGGywHrgV5E+k295aSzTwaahudk9wxAlDRng7QCOVKKVyAMmtXSNK+0iV4Y5DMyrGl4QFE68lGCDjI3EE8DIPFQ4pGcqUFe8jv5vEmlKiSK5lDruUrGcFfXJqjB4g1LUXdNM0swogyXuztyDnGAM9sH8fXNLovhqC3jthMRcvbjarOMdsEn6+nSuojiVAAoAAGOlTYwUo391XOUbQNQvnzqF60iFllC4wqMDnGOh6d+nrSahf+GfB0MDavd21p5r7EaU4LsSTgDqeSfWuuxnj1rwrTtRu7y08Q3kOlTa9I19eJfT3yogs5oMGCOMHP7tQOCOdxzjk1pSpKe+39fIU6k0t9PuPXLDV7TWtL+06UVu7Z+FkRsKSO3PIIPGDU0dtKYtigR5BG5eNuepB6k1wvwhvW8QPN4hbyxPcWcMF81s2bea5BYkoOhZVKqzDPPGTivS6dSPs5OJjyXd2Z6aXEYVjuZJbgL3kbk/XHWryKqKFUAKBgAdqdRWRdwooooAKfH3plPj7047jW409TRSHqaKm4C1xPjW1Z5rMoeBKUkPlgvtYYwpzkHODn2rtay9csxNZTNHhZcZD5Iwex4ppivytSXQ8qeGwuNFM1rcRx6ZkkARhQc4IkLg5Vg20c5xjmm3EM19pVo0F1HNdwLKXniRY2mkML7PlGQ0WSowvGea23imt7iO3O8xyEgZcBVbG0rg8Yx3weneuZvLsrKrQvDHOkclx5Al2M4D+WxPTjDEhTgHqBxWkW3sd8Pe2LXgjQrq48N6TcaZqKWN8lrb3iuqDzfNJYTpKvGUYn17eozWmt7qHgPVI7GNoV8N3t1JPHOys5t5JG3Mj452ZyQy9O4PUc5JfS+BvEklxqFsRpjySAPbOXMDNhnEigZEbMC2exP1rqNOstOdZrS01d7nTNULXkYuXSeEq6f6tcnj5uef0zXU3ze9LZ/196PIqKVKT7fmUvHXiiPxJPF4XSGa3+2zsk00O12ns14IQ995K8ejevRfAlrbz3+oxaf4Rt9JWOJ5bK9kcvFcOxwv31zuGMHacDJ9qwPDMF/omu+JTpdhDqt/pdpFHb2CDARmfEgRuuDsyBnIGBXXazpl9rfxT0X7H4ngtxp9uZLzRfO/eqCMg7RwQSVznngVUmoLkT0/p7fctdASc3rqKuieJYfBiReLfEkKa1LeRNbiBfKhhOMCMtGFLAnnnjIA5rmPDMLy6Tq19d+dbP8A2gzLNMigusSoGbuCCyH1I2571f8Ai7Yaf4igj1CHUbiz06726beahHclI4WSTKBoiPmBYkFgeMDORVvQAPDPiC08OaxeLfTR/v7S6YuzyebHubeF4z5kbYB7bfWsJtunzdX0tt/X/BOui0p3j5mZf6ZbtqklzJItxLIu1Jb7hXj3MQpVsAAbx83PAHTrWRqtm8l8bmzWKa7aKLzLYSn7OWZyqoN2QyHJ+b0HuM+m6lANR0O8XUAlysO24iNwFYJID8vXjHJ69K4CWZfswtUgS+8yJnFkrKLmeNH/AIJD95QN2ACNuzqetZQmz0KFRTSaXl/X9IYrCG0nhuYPJsLe+QRFoTKJVzwwRwXZQzbVDZ4UkVpaPBFuXy3nvED+fClwREyueQqKQGKLtOQ3ABGKu3etMPDkulPLNJq1zMsrzCA7Yoww2nzB0YAbVbPU5qslpdWccFvqEcttey2ZQRTMrSPEDuDALu2ne3I4yBx0NPmbWv8AXmHK+W4+B7e9Nx5BaeWJiscTxCMx4AO1SR93dyCc5BB9K9D8OadsSWeTG6RsjawIXAwcdhznpXK6ZaXb3EMAiikUIvTcuxDtA65HXdxxjpXpFtF5MKITkgYJPes29dDkr6+6th6IFTavQUpFL24opGVtLDSa5XW/h94b1vVH1DULBzPL/wAfCxXEkUdxxgeaisA/A7iurxzSHmqjKUXeLsIhtLaCytIrWzgit7aFQkcUSBURR0AA4AqSlNJUSuK4tFJRSTELRRRVAFPj70ynJ3qo7jW409TSUHrRWYgqrfwSzoFQjaDyn978f6VaoOcHGM+9CE1dHl2tBtT1QLNALe2jQpG5Yf63leVxhvUZ/KsyPyoD58thZXE5BdJpW8uZvug4LZ4IIGCOMCtnxTC8GqeUwxM8LyR5lCA8jdn2zjpzyKy72SOb7XJ5EWEhK71G7ylB5UFuCDvyOvOO5FaI7KM3yLTQyo4RcwwJJZPayq2NhlW4fJTJ3bhuBBJHUA7R3rnrjwjpptUmWxkSdwssk9tOLWcgnDAFDtboSTt6j0rWmv5G1C7JYGJbWG4a0WNlk+clmww5DAMpAbOcdeDUKrc3NreCzi0iKC3Z2UXLtHLCkgG95QT/ABZ3YAHT8K6oOUdU7Fyl0kijpIvfB11da5pb63eaVNa/2dd3M7R3FxbAjdDcKqfeVScEHJ6+td94X1TQrTR5/FFje6HrHiEWiW9zfq4he8l4VQw/h3MVXOM9KwrK28qwga0CKVSMLMU3PHJA4Bl/dtkoAucZ5GOvbP1Lw9aarqHnXGkW4hRo1+3IBbsHYO7EbeQoYA4YZHqKHUU/j+/uu39P5GM6Sb5oOxg65pXiW81vW/CE1/baHe6xHDepAt0z2cSxIwlizyUY8PzwfQZFbhF1YfFWO2vpmvtR0/RTJf3ttu8yc5Vo42Vfl8xArFScbhjNZtr4RsJ5rm8sDc/Z5plRhBqEjuF2jcN+7hmbn5uAMA1u6Bptvp+kRWVhYjMsweYyszF5snAmk/vMNy8kjA4PNaVaseRpfl6efl9+o6VPlmm+h1WupqLWun3txfw3tncx+awjwqsCAd2zlmKkkgDP3jxwK5W1t7XUtHhSzM76a0Tyqk5aWQqwI2IFAMZCsuCD82D0Oa0dRlbTZswfJeQXIW3eCYfuydoIO4EqpwysOwORVTXIZnvruIwXWozW0W6zjt5gsqR4VgB0I2uXG5uGXGO9cUFt/X9bnWp2VloL9pi1e4+y27zuWAkeWBm2pIixl0cc4OAp2jGQWPrV2d0ZjdedcXi3K+Zu2vLIWJIQKd3CYfjPTntVTToZ7vT1lubiOTcU8m888rKApyHOMICCCOQSR144rZT7Tc3XmQQNDIFZRcMSqzLnzGKgH7uc5Gc4GBim0loRzLb+v6/qx1Pgu1uJpprm+txE6yHawcN5q9VbjopDcA9MV2VYHgmKOHRVRCMlmY4z0J4689Mda36zZyTd5MWkoopEifypKUmk7+1BLCkoopkiUUUVIC0UlLTAKcnem05O9VF6jW409TSUp6miosIMUUdDS/Wmh2OY8a6ZPdW0N7YlvPtSWZEA3Sx4+ZATxyPzrkQHvlgutkX2YFJ4p42VQvOGTZjoQPz+gr1XHFYOp+G4LiXzrUm3kzuxH8oyDnI7Z7fSquaQnyqzPL2t0ktI3jd/tMpVi0vyyMmQdhJG3aN2MHpk4PaqunxtHdXs17bxXM0QbZfRwMJpcSYEbJj5gF6Fc8KPWuvv9AvYJf8AVOkboIZGVt64yDnB75A564FacOlIlqUtdo2DcpKhucHt9e2ewrVT0KlWjH5/1/SOAt7LTI7m8h+yNaCRpY/MhfbE52AmUqOmOuWBGSORzjRlmiFtJeuI9QlEUYf7MqNLcKSdrhAcY5PHORznggXbi2uLmwuYNVEiSmEQyy2SkPOBgsSoHyNu4255BODVy5XFqp0xI1VFaJlihRWTBXGEwcg4Bxx/FzzUSnrqbXvYxLeE+Uz/AOnGeHMAke0KHmUZQg85Kk5wSCE4qGHyJn0S3nlmh01Ha1e3W1LFplb/AFMrZ+XaueSy9u1biJLC7RCVpXm3+ZMsbKMK2AoBOejEjrxn1rOMs1isy2BhV7oxEKyYhJIy7nu7hV6Yz8vXmkp3KSu9ClPbQx2BF9ef6CtzudblzLFcI/O7zBznJUbSVA6c0+3061tppotPjij86JreRC4k8r5eISThuGbcAScAip7dxb2kVvHDcPNBMyq8arAr/NkMFXI2kYKqcn1xS3ETz2919stbO58yKIyxvIXEpMgGSMckEBd3XBA4xmquKTeq7jrRI38uFYEh2yoskc0YAeVcNnk4yFPX/ZNaGnxmbczTPMhbfE85SPaRhRwG5AO5cDHI5JzTLW0W2sWW1AtWGdzyNuBkCtuJJGX+QryCeABTNItljt4GmuZ7qTcriW3OxJRhgo/iOCG+mQTipltuTF7/ANf195pJqOp6TYIkRhkfG0SSKY9uSSHKd8gLwSPX1zZh1u/ldi9ywO8So6KDGsIALhjxknnHXr7Vlm6hnWe3int7iaAMJIkkXzCpUoFC4GCc5HTjPPpDZXDfY7MQ2skUpgLKZAqjaGCkADOcHPPUjr0qbOxooLe2pv22sztcO8d5PIWAXyXRQYsYJyOmcOO54U1s6f4hikufs15+4k2odzgqjFyQqqT1bjp15HrXJxecLOLzA7RALEqrGZflVefm+87Ng889BjrU/hyxnvpLOVctHACjb8sA4JyS2cMwP8WMkjB6VJE6ceVtnoY55pKcB7nikNUcjEoo7UE4FIQlFFFSIKKKKEAU9O/NMpy1cdwEPU0Vpf2V/wBNv/Hf/r0f2V/02/8AHf8A69dn9m4r+T8V/ma+yn2M4UVo/wBl/wDTb/xz/wCvS/2Xx/rv/Hf/AK9P+zcV/L+K/wAw9lPsZoNKK0P7L/6bf+Of/Xpf7L/6bf8Ajv8A9en/AGbif5PxX+YKlPsZxqNoYmYMY0LZznHOa1P7L/6bf+O//Xpf7L/6bf8Ajv8A9ej+zcT/AC/iv8wdKT6HP3GlWspLbdr8fN3yOh/DisW90dIZ8h8dSFJ4BJydvcf/AK67n+y/+m3/AI7/APXqOTRUfGZAQDnlM/1o/s3EveH4r/Ml0ai+A81GmyNKwTJDIQCGGNrfeIwQVOBjjHqc4qomnW6TWxFjqBmiQzee5OJD8qneFbByAp9hnFesLpIUYWQKPZMf1pf7L/6a/wDjv/16n+zMT0j+K/zNYqqlZnjUFrLZwC2W08u3ZQESKbBQLglfM27jyQMnHFMs1S/lmsxH5sSkAwxx4x34PPA55IHIPevZ20hW+86ke6Z/rQNJAziUD6J/9eq/s3E/yfiv8yvf3seY6Xo2pm4kN3HLsECqpVxh25OeQCCoIA5/xq9L4auLlJftAhy4wQAcn1OfUjuMGvQv7M/6bf8Ajv8A9ej+zP8Apt/47/8AXpf2biv5PxX+ZPJUvdaHnzeF7tZzLBdwxO6Kk223X96FGFznoQOM0h0C/mbbdtbfZgqbI4o8FWBHzEk88gnp3r0L+y/+m3/jv/16Bpf/AE2/8d/+vS/s3Ffyfiv8wtUe/wChxi+G4XaL7SSVj6KpwMA5HHTI9a3Yo0hjWONQFUYArV/sv/pt/wCO/wD16P7L/wCm3/jv/wBej+zcV/J+K/zIdOb3M3PFJnPStP8Asr/pt/47/wDXo/sr/pt/45/9ej+zcV/J+K/zD2U+xm0hrT/sr/pt/wCO/wD16P7K/wCm3/jn/wBej+zMV/J+K/zD2U+xmUVp/wBlf9Nv/Hf/AK9H9lf9Nv8Ax3/69H9mYr+T8V/mL2M+xmDkZHSitP8Asr/pt/47/wDXo/sr/pt/45/9ej+zMV/J+K/zH7KfYzKUGtH+yuf9f/47/wDXpRpWP+W3/jv/ANenHLMUn8P4r/MXsp9jLk1rUAxCra4z3Rv8aT+29R/u2n/fLf41Tf75+tN70njK/wDOyueXcvf23qP920/75b/Guc8VeMtf0y8tRYQ6c8BTMivBI7u5YKoUhwEHXLHd24rVrI8UQxNpM1w6ZaBS29R8yr/Efpjn8KqnjK6es2TOc7OzNjS/FV9fw71S0U912tlT3B+bsauDW9SyMrae+Eb/AOKrzjwO4smms5p3ub2M5eV2yXIwJM+hBZTxxzXQ+JPE2jeGrYTa1qENsCMojHLv/uqOT+ApyxGJ5+WE2wp1JSinc6O58RXdrA89y1nHDGu53KNgf+PVWHi6Y6hDZq1s000RmQiNtpXtzu/zivPPCPjc+PtUvLbTdNMeg26Fbi5uuWmLDCoqjgdySSeB0Ga622sbq11LfFc401LcRR2uwfKR3B6/gaVSviqb5ZzaZrzNaM6Jtb1HHC2mfdG/xoOt6lzhbT8Ub/Gua8Maw+uaY11JZT2bpK8TRzDn5TjNa1YvG4lO3OxOUk7Mt3GvaokRaNLMkdijf/FVymhfELxDPO6app1iscSgO0SsjM+edqsxOAOx69QTW+xIHAzyOlcr4y8PXOpwSjTZzAZ4zDMVba6jIIZDgjPUcjoxrSnjq20psynKe8WdvB4hvbiGOaD7I8Mg3K2xv8akGt6hjkWuf9xv/iq5nw1ay2dlJFcSxvK8zSkRk7Uzj5RnnjHX1JrWrJ47EJ6TZpzS6mh/beof3bX/AL4b/wCKoOt6h2Fr/wB8N/8AFVn0Uvr2I/nYc8u5Le61rxZDZPpiqD84lgkYkexDiqWl+Ldanv54by1sY4RxHIocEsOoKk9PQg+tWMVSvrM3Dp5blMkB8DqM0LHYj+dj9o+ptjXNRI+5af8AfDf40n9u6jnG20/74b/GvBvFPxOvvCurS6baKlywdnd7lWYRjcdqjBHJ6deOOD26bSfivoN3Z+dqJeznjkEDCL97GZGUELnjBJJ4Poea6HPHcqmpOzCU3F6nqn9ual2Wz/75b/Gga5qWeUtMeuxv/iqzbeVZ7eKaMhkkQOp9QRT+9cv17E3+NhzsujXdSJ4Szxz/AAN/jS/29qOCSlqMf7Df41ns208jg9KUZ3c8+3pT+vYn+dhzsvjXtRI+7ac9Pkbn9aT+3tR7LZk+m1v/AIqqGCMAEn60HIUlienQdqPr2I/nY+dl8a/qO4AraZPba3+NL/buo8Epac/7Df41mkbgMcBhjGO1Pi4XABwDgc5yPWq+u4j+di52ai61f4G4WufZG/8Aiqu6XqN3ctN56wALjbsBHr1yaw+1ZMviO0t76W08q7mljRHbyYtwAbOMn8DXRDFV7p8zYlVaepsSfeb60ynyffb60yuWRmFNkVZEZJACrAqQe4PWnUuPWpGZVlo2n6X9ok0+1ELzAByGZuB/CMk7R7DArgPHnhyD4h3LaZZrbxz6YGDamQSN2OIFx97BwWP8PQDJOOu1e9udXv5NF0WVolTi/vo+tuCP9Wh6eaQev8I5PJFTstnof2G2tYVgtoEEahRkBSQPzyec9c5raE5UHz31Kimvh3G+BPDVv4T8M2mlW+GdBvmkA/1kp+839B7AV0FIhDKCOQeazdZ1zT9FMP8AalzHbJMSEZzjJAyfoAOpNZNyqSu9WyJS6s5FodU03xk9zLNI1i7sUViTlT7dBg5/Ou/BBGQcg96wfE0TX+lpJaPkriSMjoe/UdQRVXwZrBuohZ3Dq0qglWxjI7j8KmSZs37SPMumh1GMUU40h54rNoyMPU9Zs9MvwlxIwmZflRIXkJGQMkKDgc9a17aeG6gSa2kSWFxlXQ5BFY/ivS572xFzpaK2p2wJjRm2idP4oiffHB7MAfWsP4f30LatqVtaQTrBKPOYspASQbclwQNjtuOV77c961UFKPMieZ3szuBS0tIfWs7WKEpk5cROYVV5APlVjgE+57VIenHWipcRnzx8V9HbTPHCP9oc21xZvfPb8HzNjH5M59WGCBXEXgtDYbL+zFhYTQw3DiNTuMzy5Jyeh2qMZ/rXq3xouEu/EVvDaS3cd3aiG3Dww7vmaRXIz0H8IyeK42K9uZ7jVobjQ7+aFLpZVhuDGgeWNy5Vs8gc8Hp2717+Gk/ZRb3MZTd7/wDAPcfhteyXfheGGd43lswsPyLtO3aMEj1J3V1NfPXhLxR4j0rWtUv7XTom03JV7a/fZMBt3hAw4fHO306V9A28hmtYJWXY0kaSFf7pIBx+teXiqLpyv3KpvSz3H4oFB4HFFcTRoGBijt70dO1JwOe+KYC96UHnFRkjLdM9TgdKJXKqNvLZ6VUXqFhb3zPsNyIADMY22Z/vYOP1rxrw9PdzGZpLy7urgxxeaGwkkTYIKsPYhgOO3evau1aOh/I9wwUBm25OOT1rto1XGXLbcn2SqNXKEgIc/Wm05/vMfem1kwEz79KKWipAjhgitwwgiSIMxdgigZYnJJ9yec1g+NFuPsEEtsHykvzbe49Me+MexINdDUdxBHcwSQzLuikG1h6imnrcUldWKWg3Bn06PzDmRFAb64rP8beF7XxXpH2W4by5oyzQynOFJGCCAQSCPQ+9R6JYnRbqeFrh7jcfMY7SoROxxk+vOMD0FdKDkZHSjntO8WNRailI5fwH4euvDmkNp13PHcRLIxi2ksFQ4wvIBPOT+OKztf0ybSbkXtqW8iSTPXhXJ6fQ128kiRRs8jBEUZZjwAPU+1cX/YC69q0msWHiET6dMCvlwsJI2IAG084GOvHOTSk5TblI1ouMXq7fr5HXWFyt5ZxTqMBxyPQ9xS3d1BaIr3UyRIzBAXOAWJwB9TXM+CXNo8+nTb1kQk7W7kEZOcnr1rduLjTrjUBp9xJE92iiXyW6gHOD+hrNhKHLJr+rF/uKo3lrmUzxM0Tt99kOM+59avU2baIZC2cBST+VIhOwqbti5HOKXvXK+EteN1AE1Ge1WVwrI6NsQ542/MchgRtI78Eda6sgjqOaqUXF2JUubVCdeO9FHeipsMyPEGg2er2V0r20H22SIxpOVww9s9ccY9q8x1Xwhc6Lpa3OtXf21dvkxiQbpQ3LL93rgADvnAr1+3uUuHlVAcxNtYn1pLq1gu0WO6iSVFYMAwzgjv8AWtqWIlT0T0InTUj5u8OWqoLS8a2l1O9gnZi14rqJpWbaFZP7pXPoAHFfTLDbgYAwAML0HsKpRaXYRTGaO0hWUv5m4Lzu9auGqxNf21nYcYtXuBpKX8KMVytXLErI1vxFpujXltZXczNqNyGaGziAaV1UZJwSAAPUkCofHGoXuneGrn+x45JNXuv9FsVjUE+cwO088AAAnJ9O9eJTaRqyeHLLULrS7WKOJPP+231xulnLKWbzG+UnPQrnHygY4zXVh8OqmsnZESlY9F8M/ESbxB4t/s0aL9m095Whjla5EkrkRl9+FGzZhSMhield5fySwxB4Bk5APHQdzivEfhkkNp8QtFtpZbNmnsiY49OmJjV0iZhuHQLh2OBkZxXvNXiacYSShorFRk9wg3m3iZ1w5UFvr3rS0XrP/wAB/rVJRlDjOavaN1m/4D/WlTX7xW/rQqHxFCTBc/WmGnyffOT3phzUshCUUtJUALSUUUmBx3xAvHsnspGmltrUJJI9xGu4pt2np/Fxn5e43VreFdTTUtPRkkjb5QfkOcd+v4gj2IrQ1bT7fVbF7S6UmNiGBHVWHQj3rl9J0u90DWHMog/spYVEcsbbV+8FClOoYA9QSp9qtuLh5oUU+f1Og8S20114f1KG1hS4uJLWVI4JDhZGKnCn69K5L4L6DqPh/wAKTLrenRaXfXVy0rQrN5hPAALdgeDwCf6V3+cj2NLS9q1FwWw7I42eIW/iNsYJZwDg9z7f5/St2XRdN/tqHWZYVGoRR+UJtxAxjHTpnHGaztcsZl1SK8GJImKo3H3T2Pv/APqq3q4Fwl/A27Cw+dhPvHGc4rK9nY2lJ6NPpYbfXesxeKNNt7SzSfR50kNxcE48lgMrj1yePx9q23UOjoTgMCpPpkYrlfhv4gj1/QjJHFcRGBhGROMMeOD/APWrq6ctHa1iZpxfK1ax5Rq9hZSWht9Ub7NembDM46SgfKfQ5wrAn7wAHWuh8D3t5barPot/K0rxxll3Sb8FduSCecHcccAYAOBk10ep6Na6jcJNcLIJFULmNym8A5AbHBA5xnpk1hzWMz+KbDU7fYLmGQxXO7I3xlSOMDkgEYH+FbOspR5X/TMY03e6OwoopD0rFliKqrnaqgk5OBjJ96X060tFKwBRR0FLVgNxRilpCMkfnUNWA8y+NWqxaZHpj6quoHQl3vO1jN5UkdxuXyXLYzgYfHbcRniufnGpaZoGnRaL4isfst7I6Wq6msU1tqCBA7tK5GEkbJAXPQEdTXpPjmCKaxt/NGf3oGAuciuIt/Al/JBPZaYmljQ7477yyvYnaLzP76bWUq2McDg/nXZRqwUVF/1/X9WKcLx57lP4DadaX+t6zr1xcE6nZRpplvZhVVba2wCrALwd2CB0xg+te0Vxfw78KaR4MW607TZPNu35mfkKBktsRSSQo3Z5JPNdoKjEVFUqNx2E9CePOw461f0cYabHov8AWqMOdvtV7SR88/H93p+NOl/ERVP4jOl+8TUZ6U+X75plZsyQUUlFTcYUUdqKQwqK5gjuYJIZVDI4IIIqUd80UgTtsUtNkk8vyLgqZowASB196uVzHi9J7GS31qxz5tqf3iAnEiEjcD+A/Sug0+9g1C0iurRxJDIAysKOXS4m9bE9Ujan+11uy2IxEUYZ65q9xSdxmoYzi9F1fT/D9nbnWbtbefUp5DAjAsdq554zhQMZJrtCCDzXE3HhbS9fS2i1SB2utInfyXSQq2xjnacHlTjkGuyil86JXwBu7DtQ+WyZrU5W7rfr+lh5rj/HC3lpeaZfWTssO94px1Ull+QlepwwxwQfm/A9eu7J3Y9sVleLY9Kk8M6l/wAJC4j0lYS1w5ONqjnI75zjHvRTfvaq5nqtiXw7qUOraRFcQOxx+7kVhyjjqD/T2rTrhPh9ssYCkFxJfxXk7Tpd7Nm9Co2qw7MoGDjHJ6V3Zz71crKTSBppJvqFHajqeKXp1prUQ0Kf7xyTTwMg+1GOoHNGD9KYhOKhnuYIHRJZVR3+6Cev+c1MVqC5tLe4kiknhWSSL7jMOVz/AJFS2VG19SnrNi12I2RAxjBOCevtWReahcwQiKR2gijUEmIbXK555PAP0rqSM1DceQiGS4CbeAWZc/Sl1KhO26uc/wCG2LardYlecBPmaQhmXngbu9dMKZFDHDkRxpHzyFUCpAM1SFOXM7llANgHWrul5DTdO3b61SAwOv6Vd0ofPPn/AGf61tS+NBT+Iy5OXY0zGDnn6elSPy7fWmVEiEJRRRUMYdqRhweSMelL0oqbANQcDknjvTqBxxRTWgEc8YliaNvusMH6e1cVZO/hPxDHp87KNNvizWzDhVbI+T0B5ruagu7eG6haG4QOjdiM4PrTUuW/mFk9yUMHUFTkHkGlFZ1uXsn8uVt0eMAnqfetAEMMqQRWe+o2rGXdI9tqC3MXJYbXX1XP9KvWlvFaRLBAgSJeQAOBk81MyhhhgCK5bxr4qTwytqskLSy3LHZzgYXGf50Jc2iKjGU2ox3Oq/pXM/Em0ur3wdeR2Jk81HjlKom8lVbJ+X+IDhsDrtrobWdLq2inhOUkUOM+hGf61KMg8HBpxbjJMhq+h4ppLTapG2jLLbzXM9qTctbMyIHTksOdyDjaeh59hXS+CPEl/Z63LpWqQk6XKyJaTNKpML4wY8dSmQeSc8+leisiuWLIu44ywGCfx61xfizw+5mtp7NZTD52+cQQl5OmBgAg89OvHB6A11KpGd01uZ8ritDu1Udse9H6fSq2nvObKE3W37SEHm46bu9WTjBx/wDrrAoQnnk4NLnqSCR603qR29MUmeOOe9AACGAK9CM4I5FIcgDpS559aT6daTXUoOKZLEkyFJFDqf4T3p3+c0vf/GgA+tA6j1pOtKOv0poC0v3RxirmksTJOpUgDbg+vWqY6Vd0kkNN9F/rW9Fr2iLp/EZr53Nio+w/wqSTq3NMYj04rNmSGigjJXkjHJA707gnjge9HGOmcdakLje9FKabQMKKKO9IAoooFLcZBdW4niKHG7+EkZwa4iXxc2h+MJ9I1VozCyLJEIVJdU4G9h1YEk8qPlxyD1rvu9UNa0ix1q1FvqMAkUco6krJGfVWHIohyxfvLQHdqxZs7mG8to7i0lSaCQZV0OQay/E/h2y8RW9vHfoxMEheN0cqwyMEZHYjg1w7x6v8PNSmuUzqejTsqiJAsRYnj5j90OOueAwyMA4r0PQ9Vtta0qG/shIsUhKtHKm2SJwcFGHYj/69W4cnvRd0EZuL7MfaRPbFIlUeTt2gA8IAMAflVLxN4htfD8MDXMcsskz7ERCo/hLEksQMAKfc9q2GGVI5GRjI61z2tJBpkUUt2rXEDTKgBtvtBVuzbeenXI6YpLzHTXvJWuhmteJJtLdEhsk1GTarvDHMI5FUjO7DDnjsKz7f4jaawDXVldwqQx3IyuBjqD0/TOa5zx/az2/iy5vZYw/2iCIRTInytggEHrj8a555bcR7PLmSQkJtRSdpzgcdAD6/l2q1BWPRo4WnOCbV7nsVj4h0m4MRF0baR1DrHcoYmZTjB57HNbM0gjRpJMgKMnvxXg97bzecqO8zzxqQjlmZgmenHYDJx/LFdHaazq2jwwGzMzpKjERzsZEmYMSWU4+XPTB9KTiZ1MGlrFnqENykzFU34AzkrgfSsvxN4k07w3aQzapKI0mk8tMsFBIBJyx4HANYmmeN1aFG1PT5o43k8sXECgoTt3fMD0PXj2zXTWWoafqkP+jzQTqRzHIBkexVqmOnxHLUozh00OZh8V315c3apZCwt7WdU868iJjnQjcWRgwOACMttxzxnmrPhjxpY+IJbiOzWVjbtsdvIljXJzjBdQG6dumR610gsreFQq2luijoFhUD+VLBawQvuihjjY9SqgU7xeyMhUkDsRggjsRin8Dnt70yaBZAVJKjPODWNotxqj6jcx3stnNaKSqmAcoewLbiCcdelLlGtbm7xSjk4po28hMcdqUHvTQi0BxV3Sz8034dvrVFDlQav6WeZTjjj+ta0V76Lp/EZsg5J/pUfbt7U9/vk9ajOTjHAqGZIO/alHHTrSA89aKljAjFNNLRSYxKD0Pc0UHrUsYUnccHBpaQ57YoYC/jTQck8HjilzRUN3ApazpdnrWmXGn6lF5ltOMMM4IPUMD2IPIrD8BaPJoNvf2s901xJPcmZiy7cHaF6e4AJ966mq048mZZVwAxw1VGckrX0HZMtVXv7SO9tjDKAyHkq3Q/WrAII4oqkxHK+LdKn1sWVtHc/ZmibeUjPDKBgBh3HoK4fVfD+r2PmCNLsx7kR5EBVZEUAgFRkHnt2xXsW0Bt2BnGM04ZH86tSsb0cTOirLVHjdpL5cDq6AXIIaGTeVZASQwx74A6jpVRldViZUODgtzg+vT9MfX0xXsGr6VaatC0d3F94Y3pgMPcN1FcZqvgq7h3f2ZKJYB83lA7W4bcAo6dck+uaEzrp4qE99GcrPcExwMqkMCUYAl1JDH5+38P5fjVM28N05hErxmEZURkjGR/e5znin+MDfeD9LTU7yEBhNtiR4wVdm7EHg8bjg56fjWzJpmt6ukV/DpyyQzwK6mKNIxIDjGAMDPfPpxzzWvK1FS6M3jUitmvvK+n3WqWsLG11O7Quod0Gfl46jcTt6DjB647Vt2HjjUVgjW4SOWZsBtyFdh7g9AfqM/oaqz+FdYeMp9nCoQCwHJLfxYIIwParUHhXVPMQyxqmTu3BhwPcdM57Vi3EznKjL42jdg8Z2khMd0iqGGMoSeMfnU+g6n4atITDps1tarO3nMCvl+YxHUnucAViW/gaZtgkuysZKk92XBJ69wcng8VqWngTSop2nnaWaZ8FsMVXIx0Hbp+tNW7nLNYfVJv5HSxXNtMwWK4hkbGdqOCcUGKQY8uQ9ckNzxVew0jTtNQGzs4IAoxv2jP5mrYnhzjzoc9hvGaE7HJJLoXI/uCrul8PN9F/rWPc3K2VhPdbXkiiUyFYU3s3sAOSareG/EF3dzXW7SniRVjKszv82d2RnZg4wOnrW1KLc00ODSepfk6t9ajNOf75PvTaxZKCikoqbgKaSikJAFJsBaQkZFAHHrS0twCkPX3pe9JilJDE9PWjPajFBrLYBaiuo/NgZT6ZFS9qBVeTGnZ3IrRi0I3dRx9fQ/lWf4m1Y6To93cQCN7tI8wpIDsLZxlsc4HU47A1dQPbHHzPF29V65ryz4pQTN4t0fWYrmWG2so3RwJdixyZykmTwMgMucHkAVtRSnJRbt/X6ja0cuhZ0zxrqclxE0urWU9nNCX+0JBHsjfI2qVBLMW3cKDnjB5rttN1y4jsbca1a+XeeXunEQ4Dd8LkkcYOMnGepqpZWMep2Wn3ktlbpcNGk65gVTG+0YYcfKe/bFPubK6RS07lhlegyD75PK/Tmpq1L6RVjajRh9uVzcg1KznMSpOokkXeqOdrEeuDVsj3/GsDSNR09dRXRmkf+0jD9o8uRcggk/dPrweK3ifXrQr2uzGaipWifMv7RfiT+0/FcWkW75ttMTD4PBmbBb8htHsc16h8A9eOseAoLaR83GmubZs9SnVD9MHb/wGoPjb4f0eD4e65qEGk6fFflonNylsiy7mmTcdwGcnJzzzmvQtL0bS9J8z+ytOsrHzMeZ9mgWLfjpnaBnqfzr0qlenPCxgls/ytf8AMuTTgkSXQvBCxtjE0oB2hxgE+9cZea94u0sr9u0yxlQsNzxK21R9c/Xr6V3uarxXVvOzRxyRucEFc5yO/wBa8xtJ7E05qGjSfqee23xPkjVm1DSwAhcMISwZcEYzn1B6+tX38aaldQXE1npttaW6Kzxy3M2dwHGTjgfNwOufzxe8X+FbXULWSe1Bt50+dtn3Xx6iudGj2mvaZZ2MltI+l6nCJPkPy7MHaSRjoMHPHJNb01CReIqUlC8I6v8AAr77/UvDY1TVVEszRPNbveSrJEjKx2thflVeO3I7nvVPTb25Eb3sllDcRraveyQoiqYcAqED5AGZAw55AFbVlpsGieF7rR9C02+uxp0YeK0lUnz1LFiiOeHOeSOMVhCxvb7WdYsLMtpXiEk3dlZzXGIzKGLBZCuVcbZC23pn8cdkeXWxwKEptmtDqNobl4jazxzxTQ2cgs4/MlhnkQPsYLjKLnBPK8ZzXQeE9dud941vPI8Em11ZCXUnLA4PI7VH/aNpZ63YaTd3yQatcQiRbWFS0m4AbmYnGF4J56Dmk8I3cNxe6qcOIy4kjEMWfkZnKk4PGRipcY88Xb+rHbgW23FrSx28h+dvrTadJ99vrTCTXDJmQtHej2pKgYdqQ8nnvS9qTn86QmC84OMD3p3Wmjk4P/66cucVohBRRSfNu7bf1oYwNJ0FLSVhIoQHr1paDRSAXvUckMcibHRSvpipOtB/SqbBaCKiqPlAFI6K4wwBFO70Z60XC73POfiXZCG+sNRW1luHWMxTCBWMu1TuV12kfMvzDBIznjkCmeGPG8wZLKWSTXYVgSdb6NNrOGJBQHo7r3U7W9ckV6JOQEJ2gkAjP1ry3xP4cFt502nxTtazbjPZIQFmB4JByArjswIzjBzXRTqQlH2dT5D9m5aw3/M2/i7u1n4Uao2lRy3RnEJjSKMlzidMjbjIIwcjHGDXfdq87+H/AIks5ru+sbeYy8LcuGXy/JZ2YFWXsTtBPTkmu3gvllj37GU56Hrj1pTnypUn0bf3pf5Aoycb2H6j5v2C4+zgtLsO1R3PpXmWmQeJR4pLQ3IOhjDEPHmVXHAQHqQTlicDGAPWvUY5N6BiGU+jDFcR4t8ZyaVrP2C3EZQBVYkbssRnBGDjjP5HJHFOhKTbjFXMaqS1Z3S4IGfmBHPuK4vw7BdWeoQ2U0sP2DTofsj2pUrIx3ZjmDf3CuAeOoPpXSaJftf20rPHseOTyzgHa3AOR+ePwpdS01bue3uoZntr63J8ueMAnB6owP3lPp6gEYNZxfK2mU7SVzldG+3yPqd5qHiK01q1leT7DFZ26qYcscIzLjcFPHv3rH1ddJ1iXUNPt9Q87xDoSJPdNFG0MkJGDuRuhYdRgkdQa3U06/0GGaKy0y2kilLyCS1YII5GJO/yip7nJ5NY5vby4EsD6VDaSXIEt1LFEWe5kACkyHaAB0O3nt2HPUppJv8AyRVKlOUuaItre3ksDC8uLK7uZBt+0+RGsjp6Oyj5s4wRxnPSrfhWQwzXpgUtEwQjeucH5sjI6/59az7W2lTd8wdhlVIG1SCcYx6Y7+1bnhOzjea/+WSQjYCqMfkPPp0ooz/eJs9RKEL8qO/k+/8A8C/pUUv+sNFFZdTyuoN978f61IP4fxooqFsU9hh+9/wH+lMH9aKKsXUVetSp9xvqaKKbAd/H+FMPUf7tFFSxoB2/z3pF/qKKKhjQ9fvNQ/3DRRQtxdRF+4KO7/SiikgD+/8ASm9j9P6Ciik9hjn6j8axtZ/1kP8Au0UVM9jWh8SOft/+QzqP/XKL+tdLoH/IKtPof/QqKKa3+S/Q6MR8HzL7/eP1rgJ/+R91H8P/AEAUUV1Yfd+h5eI+H5nW+Gf+QJB9P6CtX+D/AD70UVEviZtHYG7fhTj1oopRM5HP3n/HxB/1xH8mrS8B/e1L/fT+Rooq6f8AEX9dDuh8DP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Top panel: A large bone marrow megakaryocyte (thick arrow) adjacent to a bone marrow sinusoid has staining characteristics identical to those of the platelets (thin arrow) the lumen of the sinusoid. Middle panel: A megakaryocyte is extending a portion of its cytoplasm into the lumen of the sinusoid with the suggestion of platelets (arrow) budding off. Bottom panel: An entire megakaryocyte (thick arrow) has entered the sinusoid with a portion of its cytoplasm streaming ahead and forming a long proplatelet extension from the end of which platelets (thin arrow) appear to be shedding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Water color drawings by James Homer Wright using the camera lucida. From Wright, JH, J Morphol 1910; 21:263.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24402=[""].join("\n");
var outline_f23_53_24402=null;
var title_f23_53_24403="Iodoquinol and hydrocortisone: Drug information";
var content_f23_53_24403=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Iodoquinol and hydrocortisone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?13/60/14276?source=see_link\">",
"    see \"Iodoquinol and hydrocortisone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alcortin&reg; A;",
"     </li>",
"     <li>",
"      Dermazene&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F183869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Topical;",
"     </li>",
"     <li>",
"      Corticosteroid, Topical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F183857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dermatoses: Topical: Apply 3-4 times daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F5372702\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;12 years: Topical: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F183858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F183847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cream, topical: Iodoquinol 1% and hydrocortisone acetate 1% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermazene&reg;: Iodoquinol 1% and hydrocortisone acetate 1% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alcortin&reg; A: Iodoquinol 1% and hydrocortisone 2% (2 g) [contains aloe, benzyl alcohol]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F183836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F15881252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     For external use only.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F183849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of eczema (including impetiginized, nuchal, and nummular); acne urticaria; anogenital pruritus, atopic and contact dermatitis, chronic infectious dermatitis; chronic eczematoid otitis externa; folliculitis, intertrigo; lichen simplex chronicus; moniliasis; mycotic dermatoses; neurodermatitis (localized or systemic); pyoderma, stasis dermatitis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F183874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Vytone may be confused with Hytone&reg;, Zydone&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F183867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F183852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to iodoquinol, hydrocortisone, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F183839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adrenal suppression: Systemic absorption of topical corticosteroids may cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, particularly in younger children or in patients receiving high doses for prolonged periods. HPA axis suppression may lead to adrenal crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Kaposi's sarcoma: Prolonged treatment with corticosteroids has been associated with the development of Kaposi's sarcoma (case reports); if noted, discontinuation of therapy should be considered.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Optic atrophy/neuritis: Following prolonged use of iodoquinol, optic neuritis and optic atrophy have occurred; avoid long-term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peripheral neuropathy: Following prolonged use of iodoquinol, peripheral neuropathy has occurred; avoid long-term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic effects: Topical corticosteroids may be absorbed percutaneously. Absorption of topical corticosteroids may cause manifestations of Cushing's syndrome, hyperglycemia, or glycosuria. Absorption is increased by the use of occlusive dressings, application to denuded skin, or application to large surface areas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid disease: Use with caution in patients with thyroid abnormalities.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children may absorb proportionally larger amounts of corticosteroids after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F183863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F183843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: Corticosteroids may decrease the serum concentration of Telaprevir. Telaprevir may increase the serum concentration of Corticosteroids.  Management: Concurrent use of telaprevir and systemic corticosteroids is not recommended.  When possible, consider alternatives.  If used together, employ extra caution and monitor closely for excessive corticosteroid effects and diminished telaprevir effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F183844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14287245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted with this combination. Refer to individual monographs.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F183860\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14287247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F183854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Dermazene External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-1% (28.4 g): $46.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Alcortin A External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1-2-1% (2 g): $6.77",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F183851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Goedert JJ, Vitale F, Lauria C, et al, &ldquo;Risk Factors for Classical Kaposi's Sarcoma,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2002, 94(22):1712-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/53/24403/abstract-text/12441327/pubmed\" id=\"12441327\" target=\"_blank\">",
"        12441327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sirois DA, &ldquo;Oral Manifestations of HIV Disease,&rdquo;",
"      <i>",
"       Mt Sinai J Med",
"      </i>",
"      , 1998, 65(5-6):322-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/53/24403/abstract-text/9844359/pubmed\" id=\"9844359\" target=\"_blank\">",
"        9844359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8771 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24403=[""].join("\n");
var outline_f23_53_24403=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183856\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183869\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183857\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5372702\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183858\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183847\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183836\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15881252\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183849\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183874\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183867\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183852\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183839\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183863\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183843\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183844\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287245\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183860\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14287247\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183854\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183851\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8771\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8771|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?13/60/14276?source=related_link\">",
"      Iodoquinol and hydrocortisone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_53_24404="Ovarian vessels";
var content_f23_53_24404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83002&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83002&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ovarian vessels at pelvic brim",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Laparoscopic view of the ovarian vessels at the pelvic brim. The ovarian vessels supply the right ovary and tube, crossing over the pelvic brim and the bifurcation of the external and internal iliac vessels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24404=[""].join("\n");
var outline_f23_53_24404=null;
var title_f23_53_24405="Intergluteal pilonidal disease: Clinical manifestations and diagnosis";
var content_f23_53_24405=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intergluteal pilonidal disease: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Daniel J Sullivan, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24405/contributors\">",
"     David C Brooks, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Elizabeth Breen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Russell S Berman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24405/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/53/24405/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H12648617\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intergluteal pilonidal disease is an infection of the skin and subcutaneous tissue at or near the upper part of the natal cleft of the buttocks. Pilonidal cavities are not true cysts and lack a fully epithelialized lining; however, the sinus tracts may be epithelialized (",
"    <a class=\"graphic graphic_figure graphicRef87075 \" href=\"UTD.htm?9/51/10047\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1\">",
"     1",
"    </a>",
"    ]. While the presence of a pilonidal cavity may be asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/2\">",
"     2",
"    </a>",
"    ], the disease typically presents as either an acute or a chronic process [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12652900\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natal cleft, also called the intergluteal cleft, is the groove between the buttocks that extends from just below the sacrum to the perineum, superior to the anus (",
"    <a class=\"graphic graphic_figure graphicRef87078 \" href=\"UTD.htm?30/4/30798\">",
"     figure 2",
"    </a>",
"    ). The cleft or sulcus occurs as a result of the anchoring of the deep layers of the skin overlying the coccyx to the anococcygeal raphe. The cleft forms the border between the gluteus maximus muscles, which obscure the cleft when a person is upright.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651838\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of disease is approximately 26 per 100,000 population, with a mean age at presentation of 19 years for women and 21 years for men, and men are affected two to four times more often than women [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,4,5\">",
"     1,4,5",
"    </a>",
"    ]. Pilonidal disease is infrequently encountered in children and adults older than 45 years. Patient presentations are equivalently divided between acute and chronic disease; few patients present with asymptomatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for pilonidal disease include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,2,5\">",
"     1,2,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Overweight/obesity",
"      </span>",
"     </li>",
"     <li>",
"      Local trauma or irritation",
"     </li>",
"     <li>",
"      Sedentary lifestyle or prolonged sitting",
"     </li>",
"     <li>",
"      Deep natal cleft",
"     </li>",
"     <li>",
"      Family history",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12648624\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon observational studies, the contemporary theory is that pilonidal disease is acquired rather than congenital [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/6-12\">",
"     6-12",
"    </a>",
"    ]. The tendency of pilonidal disease to recur is consistent with an acquired origin. For example, if pilonidal disease were related to the presence of congenital rests of tissue that formed from the imperfect separation of the ectodermal and mesodermal layers during embryological development [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/13\">",
"     13",
"    </a>",
"    ], it would be expected that complete removal of these rests would result in a definitive cure. However, in practice, pilonidal cysts can recur following an extensive surgical resection of the affected area.",
"   </p>",
"   <p>",
"    The occasional occurrence of pilonidal cysts in locations other than the natal cleft also supports the acquired theory. These cases have occurred in locations that would be subject to local trauma from hair, such as on the hands of barbers, sheep shearers, and dog groomers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. There are also case reports of pilonidal cysts at other locations that could be exposed to hair trauma, such as the umbilicus and scalp [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12655713\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The specific mechanism for the development of pilonidal disease is unclear, although hair and inflammation are contributing factors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,14,15\">",
"     1,14,15",
"    </a>",
"    ]. As a person sits or bends, the natal cleft stretches, damaging or breaking hair follicles and opening a pore or &lsquo;pit&rsquo;. The pores collect debris and serve as fertile environment for roots of hairs shed from the head, back, or buttocks to lodge and become embedded. As the skin is drawn taut over the natal cleft with movement, negative pressure is created in the subcutaneous space, drawing hair deeper into the pore, and the friction causes the hairs to form a sinus. Pilonidal disease typically develops in people with deep natal clefts.",
"   </p>",
"   <p>",
"    Typically, pilonidal sinus tracts extend cephalad, which is likely related to the mechanical forces involved as the direction of the follicle determines the direction of the sinus tract; however, they can also extend laterally [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,14\">",
"     1,14",
"    </a>",
"    ]. Cavities may contain hair, debris, and granulation tissue, but hair follicles are rarely identified on histopathologic examination [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/12\">",
"     12",
"    </a>",
"    ]. Foreign body giant cell reaction is typically associated with the local cellular infiltrate.",
"   </p>",
"   <p>",
"    Once the pore becomes infected, an acute subcutaneous abscess develops, spreads along the tract, and may discharge its contents through a pilonidal sinus in the skin cephalad to the natal cleft (",
"    <a class=\"graphic graphic_figure graphicRef87098 \" href=\"UTD.htm?7/32/7694\">",
"     figure 3",
"    </a>",
"    ). A recurring or chronic infection can also develop in the affected area due to a retained hair or infected residue [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12648631\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651854\">",
"    <span class=\"h2\">",
"     Patient presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient presentation is highly variable, ranging from an asymptomatic pilonidal cavity or sinus to acute infections or chronic inflammation and drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. The patient may identify one or more areas of drainage (sinus tracts).",
"   </p>",
"   <p>",
"    Symptoms of an acute exacerbation include sudden onset of mild to severe pain in the intergluteal region while sitting or performing activities that stretch the skin overlying the natal cleft (eg, bending, sit-ups). The patient may also report intermittent swelling as well as mucoid, purulent,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bloody drainage in the area. Patients with chronic pilonidal disease experience recurrent or persistent drainage and pain. Fever and malaise are generally associated with an undrained abscess. There have been occasional case reports of squamous cell carcinomas arising in long-standing, neglected pilonidal sinuses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651862\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For asymptomatic patients, the physical examination reveals one or more primary pores (pits) in the midline of the natal cleft",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a painless sinus opening cephalad and slightly lateral to the cleft. For patients with acute or chronic disease, a tender mass or sinus draining mucoid, purulent,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bloody fluid can be identified. A hair may occasionally be seen protruding from a sinus opening [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24405/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Secondary tracts or pits can be identified lateral to the midline in patients with chronic or persistent complex disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651870\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific diagnostic imaging studies for acute, chronic, or asymptomatic presentations of pilonidal disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651878\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory studies are not diagnostic of pilonidal disease. However, leukocytosis may indicate an undrained abscess in the acute or chronic clinical setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12648638\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intergluteal pilonidal disease is a clinical diagnosis based upon physical examination findings of a pore (pit) or sinus in the natal cleft region. Pilonidal disease is identified by parting the buttock cheeks enough to visualize the pores or sinuses within the valley of the natal cleft. There are often a series of noninflamed pilonidal pits (pores appearing as small dimples) in the midline extending caudad.",
"   </p>",
"   <p>",
"    Patients may be asymptomatic or describe mild to severe pain with or without drainage in the intergluteal region. No imaging or laboratory studies are performed to confirm the diagnosis. When a patient presents with an acutely inflamed mass near the top of the natal cleft, the likelihood that it is an infected pilonidal cyst is extremely high.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12651894\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Perianal abscess",
"      </strong>",
"      &ndash; A perianal abscess often presents with severe pain in the anal or rectal area and constitutional symptoms such as fever and malaise are common (",
"      <a class=\"graphic graphic_picture graphicRef67524 \" href=\"UTD.htm?2/48/2820\">",
"       picture 1",
"      </a>",
"      ). On physical examination, an area of fluctuance or a patch of erythematous, indurated skin overlying the perianal skin may be noted. While anal fistula and perirectal abscess share some features with pilonidal disease, perirectal abscesses are generally near the anus, and anal fistulas generally present as either a perirectal abscess or as a draining pustule in the perianal area or on a buttock. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/40/26246?source=see_link&amp;anchor=H88522735#H88522735\">",
"       \"Perianal abscess: Clinical manifestations, diagnosis, treatment\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hidradenitis suppurativa",
"      </strong>",
"      &ndash; Hidradenitis suppurativa is a chronic follicular occlusive disease involving the intertriginous skin of the axillary, groin, perianal, perineal, and inframammary regions (",
"      <a class=\"graphic graphic_picture graphicRef69605 \" href=\"UTD.htm?6/12/6338\">",
"       picture 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef52570 \" href=\"UTD.htm?36/6/36975\">",
"       picture 3",
"      </a>",
"      ). Hidradenitis suppurativa can occur in the perirectal area and present with purulent drainage. Hidradenitis suppurativa has some characteristics in common with pilonidal disease (eg, sinus tracts, sores), but it is usually and easily distinguished by its typical location in the perineal or inguinal area. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6265?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Anorectal fistula",
"      </strong>",
"      &ndash; An anorectal fistula is the chronic manifestation of the acute perirectal process that forms an anal abscess. When the abscess ruptures or is drained, an epithelialized track can form that connects the abscess in the anus or rectum with the perirectal skin. The diagnosis of a fistula is primarily based upon characteristic findings on history and physical examination: pain, purulent drainage, and a perirectal skin lesion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12694?source=see_link&amp;anchor=H1062101#H1062101\">",
"       \"Anorectal fistula: Clinical manifestations, diagnosis, and management principles\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Perianal complications of Crohn&rsquo;s disease",
"      </strong>",
"      &ndash; Perianal complications of Crohn&rsquo;s disease included anal fissures, fistulas, and abscesses. In particular, anal fissures may be asymptomatic or present with bleeding, deep ulceration (",
"      <a class=\"graphic graphic_picture graphicRef80569 \" href=\"UTD.htm?22/16/22784\">",
"       picture 4",
"      </a>",
"      ), or anal pain, which may be worsened during evacuation. Symptoms can vary from anal pain and purulent discharge to bleeding and incontinence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=see_link&amp;anchor=H5#H5\">",
"       \"Perianal complications of Crohn's disease\", section on 'Clinical manifestations and diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Skin abscess, furuncle, carbuncle",
"      </strong>",
"      &ndash; Skin abscesses are collections of pus within the dermis and deeper skin tissues (",
"      <a class=\"graphic graphic_picture graphicRef53261 \" href=\"UTD.htm?19/51/20287\">",
"       picture 5",
"      </a>",
"      ). A furuncle is an infection of the hair follicle in which purulent material extends through the dermis into the subcutaneous tissue, where a small abscess forms. A carbuncle is a coalescence of several inflamed follicles into a single inflammatory mass with purulent drainage from multiple follicles. Furuncles and carbuncles commonly involve the buttocks (",
"      <a class=\"graphic graphic_picture graphicRef70089 \" href=\"UTD.htm?35/13/36048\">",
"       picture 6",
"      </a>",
"      ). These lesions are not associated with a sinus tract. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=see_link&amp;anchor=H3#H3\">",
"       \"Skin abscesses, furuncles, and carbuncles\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Folliculitis",
"      </strong>",
"      &ndash; Folliculitis is a superficial bacterial infection of the hair follicles with purulent material in the epidermis. Folliculitis manifests as clusters of multiple small, raised, pruritic, erythematous lesions less than 5 mm in diameter (",
"      <a class=\"graphic graphic_picture graphicRef72586 \" href=\"UTD.htm?34/19/35127\">",
"       picture 7",
"      </a>",
"      ). Pustules may be present at the centers of the lesions. Folliculitis may present with sharply demarcated areas in the setting of P. aeruginosa infection, reflecting exposure to areas of the skin in contact with contaminated water (",
"      <a class=\"graphic graphic_picture graphicRef65119 \" href=\"UTD.htm?33/14/34031\">",
"       picture 8",
"      </a>",
"      ). P. aeruginosa folliculitis may also manifest with larger lesions, up to 30 mm in diameter. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=see_link&amp;anchor=H2#H2\">",
"       \"Folliculitis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31072511\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intergluteal pilonidal disease is an infection involving the skin and subcutaneous tissue at or near the upper part of the natal cleft of the buttocks. Pilonidal cavities are not true cysts and lack a fully epithelialized lining; however, the sinus tracts may be epithelialized (",
"      <a class=\"graphic graphic_figure graphicRef87075 \" href=\"UTD.htm?9/51/10047\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12648617\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intergluteal pilonidal disease is an acquired condition likely related to the mechanical forces on the skin overlying the natal cleft, damaging or breaking hair follicles and opening a pore or &lsquo;pit&rsquo;. Cavities may contain hair, debris, and granulation tissue, but hair follicles are rarely identified on histopathologic examination. (See",
"      <a class=\"local\" href=\"#H12655713\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical presentation is highly variable, ranging from an asymptomatic pilonidal cavity to an acute infection to chronic exacerbation with inflammation and drainage. (See",
"      <a class=\"local\" href=\"#H12651854\">",
"       'Patient presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination reveals one or more primary pores (pits) in the midline of the natal cleft",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a painless sinus opening cephalad and slightly lateral to the cleft. For patients with acute or chronic disease, a tender mass or sinus draining mucoid, purulent,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bloody fluid can be identified. (See",
"      <a class=\"local\" href=\"#H12651862\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/1\">",
"      Khanna A, Rombeau JL. Pilonidal disease. Clin Colon Rectal Surg 2011; 24:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/2\">",
"      Akinci OF, Bozer M, Uzunk&ouml;y A, et al. Incidence and aetiological factors in pilonidal sinus among Turkish soldiers. Eur J Surg 1999; 165:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/3\">",
"      Jones DJ. ABC of colorectal diseases. Pilonidal sinus. BMJ 1992; 305:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/4\">",
"      Hull TL, Wu J. Pilonidal disease. Surg Clin North Am 2002; 82:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/5\">",
"      S&oslash;ndenaa K, Andersen E, Nesvik I, S&oslash;reide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis 1995; 10:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/6\">",
"      Buie, LA. Jeep disease (pilonidal disease of mechanized warfare). South Med J 1944; 37:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/7\">",
"      Patel, MR, Bassini, L, Nashad, R, et al. Barber's interdigital pilonidal sinus of the hand: a foreign body hair granuloma. J Hand Surg 1990; 15A:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/8\">",
"      MATHESON AD. Interdigital pilonidal sinus caused by wool. Aust N Z J Surg 1951; 21:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/9\">",
"      Mohanna PN, Al-Sam SZ, Flemming AF. Subungual pilonidal sinus of the hand in a dog groomer. Br J Plast Surg 2001; 54:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/10\">",
"      Allegaert WJ. Pilonidal sinus of the umbilicus. Br J Clin Pract 1967; 21:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/11\">",
"      Moyer DG. Pilonidal cyst of the scalp. Arch Dermatol 1972; 105:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/12\">",
"      DAVAGE ON. The origin of sacrococcygeal pilonidal sinuses based on an analysis of four hundred sixty-three cases. Am J Pathol 1954; 30:1191.",
"     </a>",
"    </li>",
"    <li>",
"     Mayo, OH. Observations on injuries and diseases of the rectum. Burgess and Hill, London 1833. p. 45.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/14\">",
"      da Silva JH. Pilonidal cyst: cause and treatment. Dis Colon Rectum 2000; 43:1146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/15\">",
"      Kitchen P. Pilonidal sinus - management in the primary care setting. Aust Fam Physician 2010; 39:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24405/abstract/16\">",
"      de Bree E, Zoetmulder FA, Christodoulakis M, et al. Treatment of malignancy arising in pilonidal disease. Ann Surg Oncol 2001; 8:60.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87056 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.22.229.50-9BE3393297-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24405=[""].join("\n");
var outline_f23_53_24405=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31072511\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12648617\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12652900\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12651838\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12648624\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12655713\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12648631\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12651854\">",
"      Patient presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12651862\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12651870\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12651878\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12648638\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12651894\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31072511\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/87056\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/87056|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/51/10047\" title=\"figure 1\">",
"      Pilonidal sinus and tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/4/30798\" title=\"figure 2\">",
"      Natal cleft",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/32/7694\" title=\"figure 3\">",
"      Natal cleft with pilonidal sinus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/87056|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/48/2820\" title=\"picture 1\">",
"      Perianal abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/12/6338\" title=\"picture 2\">",
"      HS abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/6/36975\" title=\"picture 3\">",
"      HS sinus1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/16/22784\" title=\"picture 4\">",
"      Anal fissure and ulcer Crohns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/51/20287\" title=\"picture 5\">",
"      Skin abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/13/36048\" title=\"picture 6\">",
"      Carbuncle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/19/35127\" title=\"picture 7\">",
"      Staphylococcal folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/14/34031\" title=\"picture 8\">",
"      Hot tub folliculitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12694?source=related_link\">",
"      Anorectal fistula: Clinical manifestations, diagnosis, and management principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/55/22387?source=related_link\">",
"      Folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/7/6265?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of hidradenitis suppurativa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/40/26246?source=related_link\">",
"      Perianal abscess: Clinical manifestations, diagnosis, treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25273?source=related_link\">",
"      Perianal complications of Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43831?source=related_link\">",
"      Skin abscesses, furuncles, and carbuncles",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_53_24406="Bullous pemphigoid axillae";
var content_f23_53_24406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple bullae and erosions arising on erythematous plaques are present in the axilla.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24406=[""].join("\n");
var outline_f23_53_24406=null;
var title_f23_53_24407="Lymph nodes body";
var content_f23_53_24407=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F64606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F64606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 579px\">",
"   <div class=\"ttl\">",
"    Lymph node groups",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 559px; height: 574px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the lymph node groups and sub-areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Celigny, P, Roy, P, Colombat, P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104:1258. Copyright &copy; 2004. American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24407=[""].join("\n");
var outline_f23_53_24407=null;
var title_f23_53_24408="Control of ventricular rate in atrial fibrillation: Nonpharmacologic therapy";
var content_f23_53_24408=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Control of ventricular rate in atrial fibrillation: Nonpharmacologic therapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24408/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/53/24408/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with atrial fibrillation (AF), the ventricular rate is controlled by the conduction properties of the atrioventricular (AV) node. In the typical patient with untreated AF, the ventricular rate can reach 150",
"    <span class=\"nowrap\">",
"     beats/min",
"    </span>",
"    or higher.",
"   </p>",
"   <p>",
"    There are two important reasons to prevent a rapid ventricular response in patients with AF:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Avoidance of hemodynamic instability",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      symptoms. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/28/6601?source=see_link\">",
"       \"Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Avoidance of a tachycardia-mediated cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27097?source=see_link\">",
"       \"Tachycardia-mediated cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with AF, a rapid ventricular response can be prevented either by restoring sinus rhythm or with therapies that reduce the ventricular response to AF. When rate control is chosen, it can usually be accomplished with pharmacologic therapy. However, some AF patients will respond poorly to or be intolerant of rate control medications. Options for such patients include reconsideration of a rhythm control strategy and nonpharmacologic methods to control the ventricular rate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=see_link\">",
"     \"Rhythm control versus rate control in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of nonpharmacologic therapies to achieve rate control in AF will be reviewed here. Pharmacologic therapies for rate control in AF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12074?source=see_link\">",
"     \"Control of ventricular rate in atrial fibrillation: Pharmacologic therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Choosing the appropriate rate control therapy for a patient with AF is guided by an understanding of the determinants of the ventricular rate and an assessment of the adequacy of rate control. The general discussion of rate control in patients with AF is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12074?source=see_link\">",
"     \"Control of ventricular rate in atrial fibrillation: Pharmacologic therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Determinants of ventricular rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;During AF, electrical activity in the atria can exceed 400",
"    <span class=\"nowrap\">",
"     beats/min.",
"    </span>",
"    The majority of these impulses do not conduct to the ventricles because of the electrical properties of the AV node. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=see_link&amp;anchor=H3660456#H3660456\">",
"     \"The electrocardiogram in atrial fibrillation\", section on 'Ventricular rate'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AV nodal tissue consists of so-called \"slow response\" fibers. In most myocardial tissue, the initial depolarizing phase of the action potential (phase 0) is mediated by rapid sodium channels. In contrast, in the slow response fibers of the AV node, phase 0 is mediated by an inward calcium current, which uses a kinetically slow channel. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relatively slow kinetics of the inward calcium current limits conduction velocity through the AV node, and therefore the ventricular rate during AF. In addition to these intrinsic properties, the AV node is also richly supplied by both components of the autonomic nervous system. AV conduction is enhanced by sympathetic fibers and slowed by parasympathetic fibers (",
"    <a class=\"graphic graphic_figure graphicRef75699 \" href=\"UTD.htm?38/48/39695\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the typical patient with untreated AF, the ventricular rate during the day varies between 90 and 170",
"    <span class=\"nowrap\">",
"     beats/min.",
"    </span>",
"    The ventricular rate may be slower (eg, less than 60",
"    <span class=\"nowrap\">",
"     beats/min)",
"    </span>",
"    in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased vagal tone.",
"     </li>",
"     <li>",
"      Drugs that affect AV nodal conduction.",
"     </li>",
"     <li>",
"      AV nodal disease &mdash; A ventricular rate below 60",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      in the absence of a drug that slows AV conduction suggests AV nodal disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A ventricular rate above 200",
"    <span class=\"nowrap\">",
"     beats/min",
"    </span>",
"    suggests one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Catecholamine excess",
"     </li>",
"     <li>",
"      Parasympathetic withdrawal",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      An accessory pathway as occurs in the preexcitation syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24311?source=see_link\">",
"       \"Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Adequacy of rate control",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several strategies for assessing the adequacy of rate control efforts. With any strategy, however, rate control should be assessed both at rest and with exertion.",
"   </p>",
"   <p>",
"    In the AFFIRM trial, heart rate targets for the patients in the rate control arm included [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Resting heart rate &le;80",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"     </li>",
"     <li>",
"      24-hour Holter average &le;100",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      and no heart rate &gt;110 percent of the age-predicted maximum",
"     </li>",
"     <li>",
"      Heart rate &le;110",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      in six minute walk",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an alternative to Holter monitoring or the six-minute walk test, the heart rate response to exertion can be assessed during submaximal or maximal exercise ECG testing [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our approach varies according to the kind of exercise the patient might do at home. Thus, for young active patients, we recommend either an exercise ECG test or a Holter during exercise. For older or sedentary patients, measuring heart rate after walking briskly around the office or up stairs may provide sufficient information.",
"   </p>",
"   <p>",
"    Regardless of the method used to measure heart rate control, the prevention of symptoms during normal activities or exercise is also a goal of therapy. It is important to consider that symptoms may be due to either inadequate rate control or relative bradycardia (eg, in patients with tachy-brady syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=see_link&amp;anchor=H5#H5\">",
"     \"Manifestations and causes of the sick sinus syndrome\", section on 'Tachycardia-bradycardia syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     AV NODAL ABLATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common nonpharmacologic method of rate control in AF is catheter-based radiofrequency ablation (RFA) of the AV node",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the His bundle. Because of the invasive nature of the procedure and the requirement for permanent pacemaker implantation, this treatment is reserved for patients in whom pharmacologic rate control therapy is either unsuccessful or not tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;RFA usually produces complete AV block; as a result, patients require implantation of a permanent pacing device to adequately control the ventricular rate (",
"    <a class=\"graphic graphic_waveform graphicRef74286 graphicRef67363 \" href=\"UTD.htm?16/10/16551\">",
"     waveform 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The efficacy of this approach is demonstrated by the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the 1998 NASPE Prospective Catheter Ablation Registry, AV nodal ablation was acutely successful in 97.4 percent of 646 patients, although 3.5 percent had recurrence of AV conduction during follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a report from the prospective Ablate and Pace trial, the procedure was successful in all but one of 156 patients who underwent RFA of the AV node [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/4\">",
"       4",
"      </a>",
"      ]. Persistent complete heart block was present in 96 percent; 33 percent of patients had no escape rhythm, while 35 percent had an escape rhythm with an escape rate &lt;40 beats per minute.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Outcomes and quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Outcomes and quality of life are significantly improved in patients with poorly controlled AF who undergo AV nodal ablation and permanent pacemaker implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. As an example, in a series of 107 such patients, ablative treatment was associated with significant reductions in [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Physician visits (5 versus 10 prior to ablation)",
"     </li>",
"     <li>",
"      Hospital admissions (0.17 versus 2.8 prior to ablation)",
"     </li>",
"     <li>",
"      Episodes of HF (8 versus 18 prior to ablation)",
"     </li>",
"     <li>",
"      Antiarrhythmic drug trials",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further support for the benefits of this approach come from a meta-analysis of 21 studies involving 1181 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/7\">",
"     7",
"    </a>",
"    ]. This report noted significant improvement in all 19 outcome measures evaluated, including quality of life, ventricular function, exercise duration, and health care use [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/7\">",
"     7",
"    </a>",
"    ]. While such benefits are often due to improved LV systolic function, improvement in some patients occurs independent of changes in LVEF and probably results from the slower and more regular heart rate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although AV nodal ablation with implantation of a permanent pacemaker improves symptoms and quality of life, it does not have either a positive or negative impact on overall survival, as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 350 patients from the Mayo Clinic, among patients without other significant cardiac disease (eg, a history of myocardial infarction or heart failure [HF], or a requirement for cardiac drug therapy) three-year survival both after ablation and with pharmacologic therapy for rate control was the same as the expected survival in the general population [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The meta-analysis discussed above found that the calculated one-year total and sudden death mortality rates after ablation and pacing therapy were comparable to those seen with medical therapy (6.3 and 2 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pacemaker selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following AV nodal ablation, patients are pacemaker dependent, therefore a functioning pacemaker must be in place prior to the ablation procedure. The choice of which type of pacing device is implanted depends upon the patients overall clinical profile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Single chamber ventricular pacemaker",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with chronic AF, a single-chamber ventricular pacemaker is adequate. After AV nodal ablation, the patient's ventricular rate will not naturally respond to increased demand, a device with rate-adaptive capabilities is used (ie, VVIR pacing). Virtually all contemporary pacemakers have rate-adaptive capabilities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link&amp;anchor=H11#H11\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\", section on 'Rate responsiveness'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Dual chamber pacemaker",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with paroxysmal AF, dual chamber pacemakers are preferred because they maintain AV synchrony during periods of sinus rhythm (eg, DDDR pacing). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link&amp;anchor=H25#H25\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\", section on 'Physiologic pacing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In order to prevent rapid ventricular pacing during episodes of AF, patients with dual chamber pacemakers following AV nodal ablation should have devices with automatic mode switching capabilities. Virtually all contemporary pacemakers have this ability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link&amp;anchor=H10#H10\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\", section on 'Mode switching'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with paroxysmal atrial fibrillation, two randomized trials demonstrated that dual chamber pacemakers with mode switching capabilities improve symptoms and quality of life compared to single chamber pacemakers or dual chamber pacemakers without mode switching capability [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients who undergo AV node ablation with pacemaker implantation for paroxysmal AF eventually progress to chronic AF [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/13\">",
"     13",
"    </a>",
"    ]. Although dual chamber pacing has not been shown to prevent this progression [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/14\">",
"     14",
"    </a>",
"    ], we favor dual chamber pacing in patients with paroxysmal AF because of the clinical benefits of physiologic pacing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/15/5367?source=see_link\">",
"     \"The role of pacemakers in the prevention of atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cardiac resynchronization therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of well-selected patients improve hemodynamically following AV junction ablation and standard RV pacing. However, RV pacing causes the RV to contract before the LV (interventricular dyssynchrony), which may impair LV systolic function, reduce functional status, and increase mortality. In patients with significant dyssynchrony due to intrinsic conduction disease or pacing, cardiac resynchronization therapy (CRT) can improve ventricular synchrony. Use of CRT in patients with AF with or without AV nodal ablation is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=see_link\">",
"     \"Cardiac resynchronization therapy in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relative efficacy of CRT with AV node ablation for rate control and pulmonary vein isolation for rhythm control in patients with HF is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24042?source=see_link&amp;anchor=H2666305#H2666305\">",
"     \"Atrial fibrillation in patients with heart failure\", section on 'AV node ablation with pacing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Implantable cardioverter-defibrillators",
"    </span>",
"    &nbsp;&mdash;&nbsp;All of the above pacing modalities (single chamber, dual chamber, CRT) and functions (rate adaptive pacing and mode switching) are available on contemporary implantable cardioverter-defibrillators (ICDs). Thus, patients with an ICD who require an AV nodal ablation procedure can often be managed without changing the device. In some cases, however, patients who did not require frequent pacing prior to the ablation will benefit from an upgrade to a dual chamber",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CRT device as they become pacemaker dependent following the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Postablation risk of VF and pacing rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although rare, the incidence of ventricular fibrillation (VF) and SCD appear to be elevated in the period following AV nodal ablation. In a review of 334 patients who underwent RFA of the AV node, nine (2.7 percent) experienced SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/15\">",
"     15",
"    </a>",
"    ]. Four events occurred within four days of the procedure, an additional three events occurred within three months, and two occurred late and were thought to be unrelated to the procedure.",
"   </p>",
"   <p>",
"    Possible causes of postablation VF include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underlying heart disease",
"     </li>",
"     <li>",
"      Activation of the sympathetic nervous system",
"     </li>",
"     <li>",
"      Prolongation in action potential duration",
"     </li>",
"     <li>",
"      Repolarization abnormalities induced by bradycardia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential for reducing the frequency of early VF with postablation pacing at a higher rate was evaluated in a report of 235 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/17\">",
"     17",
"    </a>",
"    ]. The incidence of VF was 6 percent in the first 100 patients in whom the postablation chronic pacing rate was &le;70 beats per minute. In the next 135 patients, however, a pacing rate of 90 was used for the first three months after the ablation and there were no episodes of VF.",
"   </p>",
"   <p>",
"    Pacing at a rate of 90 beats per minute decreases sympathetic activity, which may contribute to the reduction in VF or SCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Need for anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;While AV nodal ablation results in adequate heart rate control, it does not stop the atria from fibrillating. Thus, the risk of thromboembolic events is not affected [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/18\">",
"     18",
"    </a>",
"    ]. As a result, there is a need for long-term anticoagulation similar to that in patients with chronic AF whose heart rate control is achieved pharmacologically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     AV NODAL CONDUCTION MODIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another method to control the ventricular rate in AF is to modify, rather than completely abolish, AV nodal conduction. RFA applied to a section of the AV node (eg, the slow pathway) can reduce the number of impulses that successfully reach the infranodal conduction system and the ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/19-23\">",
"     19-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, although AV nodal modification may eliminate the need for a pacemaker, it is less effective than AV nodal ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/22,24,25\">",
"     22,24,25",
"    </a>",
"    ]. In a series of 120 patients, 60 of whom underwent AV nodal ablation and 60 of whom underwent AV nodal modification [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/24\">",
"     24",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All patients undergoing AV nodal ablation had complete AV block produced and pacemaker implantation.",
"     </li>",
"     <li>",
"      Full or partial success with AV nodal modification was achieved in 57 percent of patients.",
"     </li>",
"     <li>",
"      Among patients in whom AV nodal modification failed, complete AV block (with pacemaker implantation) was deliberately induced in nine patients (15 percent).",
"     </li>",
"     <li>",
"      During an average follow-up of 26 months, recurrence of AF with a rapid rate was more frequent in those with AV nodal modification (12 versus 6 percent with AV nodal ablation).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Direct comparison of these outcomes is limited by the relatively high crossover rate, the higher prevalence of PAF as opposed to chronic AF in the group treated with AV nodal modification (72 versus 40 percent with AV nodal ablation), and the ongoing use of both rate control and antiarrhythmic drugs in both groups.",
"   </p>",
"   <p>",
"    Further limitations to the AV nodal modification procedure include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A tendency for the ventricular response to increase over time",
"     </li>",
"     <li>",
"      Poor control during periods of increased sympathetic tone [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Induction of complete AV block in 15 to 20 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/19,24,26\">",
"       19,24,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For all of these reasons, AV nodal modification is now rarely recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INVESTIGATIONAL METHODS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Para-Hisian pacing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac resynchronization therapy (CRT or BiV pacing) is a strategy to avoid the dyssynchrony associated with standard RV apical pacing in patients who become pacemaker dependent after AV nodal ablation. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Cardiac resynchronization therapy'",
"    </a>",
"    above.) A potential alternative to CRT is the positioning of a single pacing lead near the His bundle (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56944 \" href=\"UTD.htm?28/24/29056\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A pacing lead near the His bundle will activate the native conduction system, resulting in less dyssynchrony and a more normal QRS complex (",
"    <a class=\"graphic graphic_waveform graphicRef78017 \" href=\"UTD.htm?30/1/30736\">",
"     waveform 2",
"    </a>",
"    ). It is technically difficult to place a conventional pacing lead in a position that results in capture of the His bundle at a reasonable pacing output because the His-bundle is insulated from the endocardium. Newer, small caliber, screw-in pacing leads that are delivered using a guiding sheath rather than a stylet may improve the ability to accomplish permanent para-Hisian capture.",
"   </p>",
"   <p>",
"    The value of this approach was evaluated in a crossover trial of 16 patients who underwent AV nodal ablation and permanent pacemaker placement [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/27\">",
"     27",
"    </a>",
"    ]. All patients had one pacing lead placed in the RV apex and a second lead high on the RV septum, where para-Hisian pacing was confirmed. The patients were randomly assigned to para-Hisian pacing or apical pacing for six months, then crossed over to the other pacing mode for an additional six months.",
"   </p>",
"   <p>",
"    The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During para-Hisian pacing, the average QRS duration was 121 msec, compared to 88 msec at baseline and 179 msec with RV apical pacing.",
"     </li>",
"     <li>",
"      The mean NYHA functional class was better with para-Hisian pacing (1.8) compared to either baseline or with RV apical pacing (2.3 and 2.5, respectively).",
"     </li>",
"     <li>",
"      Mitral regurgitation and six-minute walk test results were both better with para-Hisian pacing compared to baseline or RV apical pacing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Para-Hisian pacing is technically difficult to accomplish. In addition, lead dislodgement may be more likely compared with conventional pacing sites. Lead dislodgement would have serious complications in this setting due to complete heart block after ablation of the AV node.",
"   </p>",
"   <p>",
"    Further studies in larger populations are necessary to clarify both the clinical benefits and safety of this approach. In addition, given the risks of lead dislodgement, the safety and efficacy of para-Hisian pacing should be compared against biventricular pacing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Low atrial isolation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Instead of creating AV block by ablation of the AV node or His bundle, it is theoretically possible to isolate the AV node by creating an ablation line in the lower right atrium, from the tricuspid annulus to the coronary sinus and then to the intraatrial septum (",
"    <a class=\"graphic graphic_figure graphicRef53224 \" href=\"UTD.htm?28/20/28995\">",
"     figure 2",
"    </a>",
"    ). If successful, the isolated lower segment of the atrium will be electrically independent from the rest of the atria.",
"   </p>",
"   <p>",
"    In a patient with AF, such an ablation line would have the following effects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AV block, due to isolation of the AV node and a small region of atrial tissue from the rest of the atria.",
"     </li>",
"     <li>",
"      Creation of an area of low atrial tissue, electrically isolated from the fibrillating atria, that may be paced by a lead placed within that area.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In theory, pacing from a lead positioned in this isolated atrial region would result in conduction through the AV node and the His-Purkinje system, producing a normal QRS complex and avoiding the dyssynchrony associated with RV apical pacing. Such an approach has several potential advantages over para-Hisian pacing (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Para-Hisian pacing'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lead placement may be easier and is likely to be more stable",
"     </li>",
"     <li>",
"      The patient is more likely to have a stable escape rhythm, due to preservation of the AV node and His-Purkinje system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This approach has been tested in an isolated swine heart model [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/28\">",
"     28",
"    </a>",
"    ]. In a series of five hearts, electrical isolation was successfully achieved, and pacing formed within the isolated segment resulted in normal AV conduction without direct capture of the ventricles.",
"   </p>",
"   <p>",
"    This approach is entirely investigational. Published experience is limited to this small series of animal hearts, and substantial additional study will be necessary before this procedure can be considered in clinical practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Ventricular rate regularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular rate regularization, or ventricular rate stabilization, is a pacemaker mode that can attenuate the rate and irregularity of the ventricular response during AF [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/29\">",
"     29",
"    </a>",
"    ]. The ventricle is paced at a variable rate at or near the mean native rate. This causes concealed retrograde conduction into the AV node, which makes it refractory to subsequent anterograde impulses from the atria. This tends to reduce the number of short RR intervals, which may improve symptoms by making the ventricular rate slower and more regular during AF. A potential advantage of this approach is that no catheter ablation of the AV junction is performed. However, this technique may be less effective at controlling AF during physical activity than at rest.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Gene therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A novel approach to modify the AV node and produce rate control is gene therapy. This was examined in an animal study in which the heart was infected with recombinant adenovirus encoding the G-alpha(i2) subunit, an inhibitory component of the beta adrenergic signaling pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/30\">",
"     30",
"    </a>",
"    ]. The overexpression of G-alpha(i2) mimicked the effect of beta blockers, suppressing AV nodal conduction and slowing the heart rate during AF, without producing complete heart block.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following recommendations are in general agreement with those made in the 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/European",
"    </span>",
"    Society of Cardiology guidelines on atrial fibrillation&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/2\">",
"     2",
"    </a>",
"    ]. Recommendations regarding nonpharmacologic therapy to control the ventricular rate in atrial fibrillation were not changed in the 2011 focused update [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24408/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These recommendations apply to patients with AF in whom a rate control strategy has been chosen (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=see_link\">",
"     \"Rhythm control versus rate control in atrial fibrillation\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with chronic or paroxysmal AF with a rapid ventricular response, we recommend pharmacologic therapy to control the ventricular rate as an initial approach (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12074?source=see_link\">",
"       \"Control of ventricular rate in atrial fibrillation: Pharmacologic therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with chronic or paroxysmal AF with a rapid ventricular response who do not respond to or are intolerant of pharmacologic therapy, we suggest AV nodal ablation in association with implantation of a permanent pacemaker (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'AV nodal ablation'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      For patients who undergo AV nodal ablation, the appropriate type of pacemaker depends upon the clinical scenario. A single chamber ventricular pacemaker with rate adaptive capability is appropriate for patients with chronic AF (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Single chamber ventricular pacemaker'",
"      </a>",
"      above), and a dual chamber pacemaker with both mode switching and rate adaptive capabilities is appropriate for patients with paroxysmal AF. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Dual chamber pacemaker'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"       \"Modes of cardiac pacing: Nomenclature and selection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The potential role of CRT in patients with AF undergoing AV nodal ablation is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=see_link\">",
"       \"Cardiac resynchronization therapy in atrial fibrillation\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In addition, some patients undergoing AV nodal ablation and pacemaker implantation may benefit from implantation of an internal cardioverter-defibrillator (ICD) for standard criteria related to primary or secondary prevention of SCD. All of the pacing modalities discussed above (ie, ventricular, dual chamber, and CRT) can be accomplished with devices that include ICD capabilities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=see_link\">",
"       \"Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=see_link\">",
"       \"Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with AF who are at high risk for thromboembolic events, we recommend chronic anticoagulation therapy unless there is a contraindication, regardless of whether they are treated with a rhythm control, pharmacologic rate control, or nonpharmacologic rate control strategy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Need for anticoagulation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"       \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In patients for whom a rhythm control strategy is chosen, there are also nonpharmacologic therapeutic options. These procedures are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"       \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/15/5367?source=see_link\">",
"       \"The role of pacemakers in the prevention of atrial fibrillation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=see_link\">",
"       \"Surgical approaches to prevent recurrent atrial fibrillation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/1\">",
"      Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/2\">",
"      Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006; 48:e149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/3\">",
"      Rosenquvist M, Lee MA, Moulinier L, et al. Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction. J Am Coll Cardiol 1990; 16:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/4\">",
"      Curtis AB, Kutalek SP, Prior M, Newhouse TT. Prevalence and characteristics of escape rhythms after radiofrequency ablation of the atrioventricular junction: results from the registry for AV junction ablation and pacing in atrial fibrillation. Ablate and Pace Trial Investigators. Am Heart J 2000; 139:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/5\">",
"      Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/6\">",
"      Fitzpatrick AP, Kourouyan HD, Siu A, et al. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996; 131:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/7\">",
"      Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation 2000; 101:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/8\">",
"      Brown CS, Mills RM Jr, Conti JB, Curtis AB. Clinical improvement after atrioventricular nodal ablation for atrial fibrillation does not correlate with improved ejection fraction. Am J Cardiol 1997; 80:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/9\">",
"      Weerasooriya R, Davis M, Powell A, et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol 2003; 41:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/10\">",
"      Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/11\">",
"      Marshall HJ, Harris ZI, Griffith MJ, et al. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. Circulation 1999; 99:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/12\">",
"      Kamalvand K, Tan K, Kotsakis A, et al. Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias. J Am Coll Cardiol 1997; 30:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/13\">",
"      Gribbin GM, Bourke JP, McComb JM. Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias. Heart 1998; 79:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/14\">",
"      Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation 2000; 102:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/15\">",
"      Ozcan C, Jahangir A, Friedman PA, et al. Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 2002; 40:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/16\">",
"      Hamdan MH, Page RL, Sheehan CJ, et al. Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation. J Am Coll Cardiol 2000; 36:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/17\">",
"      Geelen P, Brugada J, Andries E, Brugada P. Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1997; 20:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/18\">",
"      Gasparini M, Mantica M, Brignole M, et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up. Heart 1999; 82:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/19\">",
"      Williamson BD, Man KC, Daoud E, et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994; 331:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/20\">",
"      Canby RC, Rom&aacute;n CA, Kessler DJ, et al. Selective radiofrequency ablation of the \"slow\" atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation. Am J Cardiol 1996; 77:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/21\">",
"      Della Bella P, Carbucicchio C, Tondo C, Riva S. Modulation of atrioventricular conduction by ablation of the \"slow\" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter. J Am Coll Cardiol 1995; 25:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/22\">",
"      Kreiner G, Heinz G, Siostrzonek P, G&ouml;ssinger HD. Effect of slow pathway ablation on ventricular rate during atrial fibrillation. Dependence on electrophysiological properties of the fast pathway. Circulation 1996; 93:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/23\">",
"      Strickberger SA, Weiss R, Daoud EG, et al. Ventricular rate during atrial fibrillation before and after slow-pathway ablation. Effects of autonomic blockade and beta-adrenergic stimulation. Circulation 1996; 94:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/24\">",
"      Proclemer A, Della Bella P, Tondo C, et al. Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation. Am J Cardiol 1999; 83:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/25\">",
"      Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 1998; 21:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/26\">",
"      Morady F, Hasse C, Strickberger SA, et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 1997; 29:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/27\">",
"      Occhetta E, Bortnik M, Magnani A, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 2006; 47:1938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/28\">",
"      L&uuml; F, Iaizzo PA, Benditt DG, et al. Isolated atrial segment pacing: an alternative to His bundle pacing after atrioventricular junctional ablation. J Am Coll Cardiol 2007; 49:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/29\">",
"      Wood MA. Trials of pacing to control ventricular rate during atrial fibrillation. J Interv Card Electrophysiol 2004; 10 Suppl 1:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/30\">",
"      Donahue JK, Heldman AW, Fraser H, et al. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med 2000; 6:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24408/abstract/31\">",
"      Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123:104.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1012 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.65.66-4367187BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24408=[""].join("\n");
var outline_f23_53_24408=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Determinants of ventricular rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Adequacy of rate control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      AV NODAL ABLATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Outcomes and quality of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pacemaker selection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Single chamber ventricular pacemaker",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Dual chamber pacemaker",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cardiac resynchronization therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Implantable cardioverter-defibrillators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Postablation risk of VF and pacing rates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Need for anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      AV NODAL CONDUCTION MODIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INVESTIGATIONAL METHODS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Para-Hisian pacing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Low atrial isolation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Ventricular rate regularization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Gene therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1012\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1012|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/24/29056\" title=\"diagnostic image 1\">",
"      Para Hisian pacing lead",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1012|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/48/39695\" title=\"figure 1\">",
"      AV nodal physiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/20/28995\" title=\"figure 2\">",
"      Low atrial isolation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1012|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/10/31905\" title=\"waveform 1A\">",
"      EP study tracings AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?20/44/21186\" title=\"waveform 1B\">",
"      EP study tracings RF catheter ablation of the AV junction in AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?30/1/30736\" title=\"waveform 2\">",
"      Para Hisian pacing ECG",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24042?source=related_link\">",
"      Atrial fibrillation in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24311?source=related_link\">",
"      Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=related_link\">",
"      Cardiac resynchronization therapy in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12074?source=related_link\">",
"      Control of ventricular rate in atrial fibrillation: Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/28/6601?source=related_link\">",
"      Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/31/22008?source=related_link\">",
"      Manifestations and causes of the sick sinus syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=related_link\">",
"      Modes of cardiac pacing: Nomenclature and selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38422?source=related_link\">",
"      Myocardial action potential and action of antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=related_link\">",
"      Rhythm control versus rate control in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/62/15338?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43385?source=related_link\">",
"      Role of implantable cardioverter-defibrillators for the secondary prevention of sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=related_link\">",
"      Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/45/37591?source=related_link\">",
"      Surgical approaches to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27097?source=related_link\">",
"      Tachycardia-mediated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=related_link\">",
"      The electrocardiogram in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/15/5367?source=related_link\">",
"      The role of pacemakers in the prevention of atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_53_24409="Complex endometrial hyperplasia";
var content_f23_53_24409=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Complex endometrial hyperplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Silverberg SG, Kurman RJ. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. AFIP Atlas of Tumor Pathology, version 2.0, American Registry of Pathology, Washington DC 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24409=[""].join("\n");
var outline_f23_53_24409=null;
var title_f23_53_24410="Risk factors for the development of melanoma";
var content_f23_53_24410=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk factors for the development of melanoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Clara Curiel-Lewandrowski, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Michael B Atkins, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Hensin Tsao, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/53/24410/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/53/24410/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanoma is the most serious form of skin cancer. The rapid increase in the incidence of melanoma and its associated mortality require a detailed understanding of the risk factors associated with melanoma.",
"   </p>",
"   <p>",
"    Here we will review epidemiologic changes in the incidence and mortality, specific risk factors, and the management of patients at high risk for the development of melanoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5112797\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of melanoma is rising dramatically, and despite efforts at screening, mortality has not decreased appreciably. Understanding the epidemiology provides information about important causative factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5112804\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of melanoma is increasing. Based upon data obtained between 2004 and 2006, the lifetime probability of developing melanoma in the United States is estimated to be 1 in 37 for men and 1 in 56 for women. This risk is substantially greater than noted in 1985 and 1965, when the lifetime risks for both sexes combined were estimated to be 1 in 150 and 1 in 600, respectively. In the United States, melanoma is the fifth leading cancer in men and the seventh in women [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence rates for invasive melanoma among white individuals in the United States in the years 2003 to 2007 were",
"    <span class=\"nowrap\">",
"     25.4/100,000",
"    </span>",
"    men and",
"    <span class=\"nowrap\">",
"     16.9/100,000",
"    </span>",
"    women per year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/2\">",
"     2",
"    </a>",
"    ]. From 1992 through 2006, the incidence increased by more than 3 percent per year among non-Hispanic whites [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/3\">",
"     3",
"    </a>",
"    ]. The increase was observed in both sexes and in all age groups and was highest in individuals aged 65 and older [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/3\">",
"     3",
"    </a>",
"    ]. Lentigo maligna melanoma has been increasing at a higher rate compared to other subtypes of melanoma combined for patients aged 45 and older [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the incidence of melanoma in the United States may be underestimated because many cases diagnosed and treated in private practices are not reported to cancer registries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of melanoma is also rising worldwide. The estimated age-standardized incidence rates of melanoma in men and women worldwide increased from 2.3 and",
"    <span class=\"nowrap\">",
"     2.2/100,000",
"    </span>",
"    people, respectively, in 1990 to 3.1 and",
"    <span class=\"nowrap\">",
"     2.8/100,000",
"    </span>",
"    people in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Between the early 1970s and 2000, the estimated incidence of melanoma in central Europe increased from 3 to 4",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    inhabitants per year to 10 to 15",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    inhabitants per year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/9\">",
"     9",
"    </a>",
"    ]. In contrast to North America and Australia, European incidence rates of melanoma in females exceed those in men [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some investigators have suggested that the reported increase in melanoma incidence results at least in part from of an increasing number of skin biopsies and significant variability in the histological interpretation of early evolving lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/11\">",
"     11",
"    </a>",
"    ]. However, this explanation does not account for the increase in melanoma mortality rates, particularly in older men.",
"   </p>",
"   <p>",
"    Others have speculated that the increasing incidence of melanoma is related to a rise in screening for melanoma, leading to the detection of thinner, more indolent lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/12\">",
"     12",
"    </a>",
"    ]. However, a study of SEER data (1992-2004) from non-Hispanic whites found increasing incidence of melanoma of all thicknesses and among all socioeconomic levels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/13\">",
"     13",
"    </a>",
"    ]. Individuals of low socioeconomic status, who were believed to be less likely to have access to screening services, exhibited the highest increase in melanoma incidence when compared with subjects with higher socioeconomic status. In a study of a population based screening program, the incidence of in situ and invasive melanomas in the screened population increased throughout the one-year screening period, but returned to baseline levels in the three years after the screening program was discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/14\">",
"     14",
"    </a>",
"    ]. In the control region, by contrast, a small increase in incidence was observed throughout the study period. These results suggest that screening accounts for some, but not all, of the increase in melanoma incidence.",
"   </p>",
"   <p>",
"    Melanoma is rare in children and adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], and approximately 90 percent of these cases are in those &ge;10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/16\">",
"     16",
"    </a>",
"    ]. An analysis of the SEER database showed that the incidence in those less than 20 years of age is increasing by 2.9 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/15\">",
"     15",
"    </a>",
"    ]. Melanomas in children may present as thicker, more advanced lesions, with a poorer prognosis, possibly because of a lack of awareness, a delay in diagnosis, and a higher rate of nodular melanomas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5112823\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;In Australia, a trend towards a decrease in melanoma mortality rates between the late 1980s and 2002 was demonstrated for both men and women aged 35 to 54 years (-2.4 and -2.9 percent per year, respectively), whereas the rates remained stable for those aged 55 to 79 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/18\">",
"     18",
"    </a>",
"    ]. In the United States, from 2002 through 2006, the mortality rates decreased in men and women younger than 65 years, but increased for older individuals (+6.6 percent for men and +0.6 percent for women) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/3,19\">",
"     3,19",
"    </a>",
"    ]. The decline in mortality noted in younger patients may represent the effects of public education on early detection and treatment.",
"   </p>",
"   <p>",
"    There are no clinical trials demonstrating that screening decreases the mortality from melanoma. However, five years after the completion of a screening program involving about 400,000 participants in Germany, the mortality rates from melanoma in the screened area were 50 percent lower than those observed in the nonscreened area [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link\">",
"     \"Screening and early detection of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk factors for developing melanoma are both environmental and genetic, as discussed below. The interplay of these factors likely accounts for the wide variation in melanoma incidence in different ethnic groups and geographic areas, as evidenced by the following [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an analysis from the SEER database from 2000 to 2004, the male incidence rates in whites, Hispanics,",
"      <span class=\"nowrap\">",
"       Asians/Pacific",
"      </span>",
"      islanders, blacks, and native Americans were 27.2, 4.5, 1.7, 1.1, and 4.1 per 100,000 individuals, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lower extremity lesions were more common among non-white groups, as were acral lentiginous lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An increased incidence of melanoma is associated with an increased UV index and lower latitude only in non-Hispanic whites. No evidence to support the association of UV exposure and melanoma incidence in black or Hispanic populations was observed [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Correlation of melanoma incidence with environmental exposure and biological traits points to multiple elements that may predispose an individual to melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/24-26\">",
"     24-26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sun exposure and UV radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a direct causal relationship between solar ultraviolet (UV) radiation and melanoma cannot be demonstrated experimentally, the evidence from indirect studies is overwhelming and leaves little doubt that UV exposure is a major risk factor for melanoma:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical and epidemiologic evidence demonstrates higher rates of melanoma in people with extensive or repeated intense exposure to sunlight. The majority of melanomas develop on sun-exposed skin, particularly in areas that are more susceptible to sunburn. Individuals with naturally dark skin or whose skin darkens easily upon sun exposure have lower rates of melanoma, supporting the concept that greater penetration of UV light into the skin results in a higher risk [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Timing and pattern of sun exposure'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The major case-control studies assessing sun exposure, sunburn, and melanoma incidence were analyzed in a systematic review [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/28\">",
"       28",
"      </a>",
"      ]. Intermittent exposure and sunburn in adolescence or childhood were strongly associated with an increased risk of melanoma, while occupational exposure did not confer an increased risk. These findings support the hypothesis that melanoma risk is affected primarily by intermittent intense sun exposure. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Timing and pattern of sun exposure'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Adjusted for skin type, the geographic incidence of melanoma is highest in equatorial areas and decreases proportionately with distance from the equator, with its correspondingly lower level of UV exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/29\">",
"       29",
"      </a>",
"      ]. An apparent north-south gradient has been observed in melanoma mortality in the United States among Caucasians [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/30\">",
"       30",
"      </a>",
"      ] (",
"      <a class=\"external\" href=\"file://www3.cancer.gov/atlasplus/\">",
"       www3.cancer.gov/atlasplus/",
"      </a>",
"      ). The lowest rates were in the North, while the highest were in the Southeastern and South Central regions. Geographic variation in melanoma and nonmelanoma skin cancer rates is also documented in African Americans [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A population-based study of survival in patients diagnosed with melanoma has generated controversy by suggesting that some factors associated with high levels of sun exposure, such as solar elastosis and, to a lesser extent, sunburns and intermittent sun exposure, are inversely associated with mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/32\">",
"       32",
"      </a>",
"      ]. If these results are confirmed, it could potentially lead to interventions, such as stimulation of the vitamin D pathway or DNA repair capacity cancers. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=see_link&amp;anchor=H932772#H932772\">",
"       \"Primary prevention of melanoma\", section on 'Vitamin D'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Studies strongly indicate that a decrease in recreational sun exposure following the diagnosis of primary melanoma, and thus a change in future individual behavior, can significantly diminish the chance of a second primary melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     UV-A versus UV-B irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultraviolet B radiation (UV-B, wavelengths 290 to 320 nanometers) appears more closely associated with the development of melanoma than UV-A (wavelengths 320 to 400 nanometers). This is supported by the higher incidence of melanoma in equatorial regions than in latitudes farther from the equator, as UV-B radiation is most intense at the equator while UV-A intensity varies less across latitudes.",
"   </p>",
"   <p>",
"    Although UV-B appears to be more important than UV-A as a risk factor, a causal link to UV-A exposure is also supported by data from patients using tanning beds and or treated with PUVA for psoriasis. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Tanning beds'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H10\">",
"     'PUVA therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Timing and pattern of sun exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern and timing of sun exposure appear to be important for skin cancer. Nonmelanoma cancers are associated with cumulative sun exposure and occur most frequently in areas maximally exposed to the sun (eg, face, dorsal hands, forearms).",
"   </p>",
"   <p>",
"    In contrast, melanomas tend to be associated with intense, intermittent sun exposure and sunburns and they frequently occur in areas exposed to the sun only sporadically (eg, the back in men, the legs in women) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. This association with intermittent sun exposure may not be true for all body sites; for example, melanomas of the head and neck are more frequent in patients with high occupational sun exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exposure during childhood seems particularly important. Individuals who have had five or more severe sunburns in childhood or adolescence have an estimated twofold greater risk of developing melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/35\">",
"     35",
"    </a>",
"    ]. Moreover, the incidence of melanoma is higher among people who migrate from northern to more equatorial latitudes; this effect is seen predominantly among those who were children at the time of migration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not clear why intermittent extreme sun exposure appears to increase the risk of melanoma, whereas chronic suberythemogenic exposure is associated more with nonmelanoma skin cancer. After severe UV radiation-induced DNA damage, keratinocytes (from which squamous and basal cell carcinomas arise) undergo apoptosis, or programmed cell death. In contrast, melanocytes are resistant to this level of radiation, and their survival results in the propagation of mutated genes, especially if damaged DNA is not fully repaired [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/27,41\">",
"     27,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This may be an evolutionarily selected advantage for the organism, as the melanocytes survive a sunburn and can protect regenerating keratinocytes. However, on a cellular level, melanocytes that have suffered mutation of growth-regulating genes may have an unwanted growth advantage, resulting in disordered control of cell cycling and replication. Despite the high mortality associated with melanoma, the mechanisms that diminish melanocyte apoptosis may paradoxically be evolutionarily selected, as melanomas most often arise after the age of childbearing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Tanning beds",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the 1920s \"sun therapy\" gained popularity as a cure for multiple maladies. The French fashion designer Gabrielle \"Coco\" Chanel further glamorized the deep tan as a status symbol. Fifty years later, commercial tanning beds, which emit UV-A light, became widespread. Results from the United States 2010 National Health Interview Survey reveal that nearly a third of white women aged 18 to 25 years reported indoor tanning in the past year, with an average of 20 sessions per year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/42\">",
"     42",
"    </a>",
"    ].&nbsp;",
"   </p>",
"   <p>",
"    Evidence now suggests that tanning beds increase the risk for melanoma. In 2009, the World Health Organization International Agency for Research on Cancer (IARC) classified ultraviolet light emitted from tanning beds as a human carcinogen, based upon evidence from multiple studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/43\">",
"     43",
"    </a>",
"    ]. Because tanning beds have been popular for only 30 years, epidemiologic data regarding their contribution to melanoma risk is still developing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 19 population based case-control studies and one cohort study found a modest increase of risk for &ldquo;ever&rdquo; versus &ldquo;never&rdquo; exposed to sunbeds (summary RR 1.15, 95% CI 1.00&ndash;1.31). However, a 75 percent increase in the risk of cutaneous melanoma was found among individuals who utilized tanning devices before the age of 35 (RR 1.75, 95% CI 1.35-2.26) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Two subsequent case-control studies and a large prospective cohort study further support the association between tanning devices and melanoma, demonstrating increasing risk with total hours, sessions, or years of use [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/45-47\">",
"       45-47",
"      </a>",
"      ]. The risk seems to be higher for the newer high",
"      <span class=\"nowrap\">",
"       speed/high",
"      </span>",
"      intensity, and high pressure devices compared with the conventional ones [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/45\">",
"       45",
"      </a>",
"      ] and for use started in the first decades of life [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Case-control studies have found an association between tanning devices and ocular melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/48,49\">",
"       48,49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     PUVA therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/23/33136?source=see_link\">",
"     methoxsalen",
"    </a>",
"    (psoralen) and ultraviolet A radiation (PUVA), used in the treatment of psoriasis and other skin conditions, is associated with a late increase in the risk of melanoma. In a multicenter series of 1380 patients with severe psoriasis who were first treated with PUVA in 1975 and 1976, the incidence of invasive or in situ cutaneous melanomas was not elevated above that expected in the general population in the first 15 years following treatment. However, the incidence rate for all melanomas was increased five-fold between 16 and 20 years, and more than 12 times than expected beyond 20 years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/50\">",
"     50",
"    </a>",
"    ]. The amount of PUVA treatment was also a factor; patients who received high doses of PUVA had a greater risk for melanoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40042?source=see_link&amp;anchor=H23#H23\">",
"     \"Treatment of psoriasis\", section on 'Ultraviolet light'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other factors have been evaluated as possible risk factors for melanoma.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Occupational &mdash; Exposure to occupational factors has been examined in a number of studies focusing on polychlorinated biphenyls (PCBs), petroleum products, ionizing radiation, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"       selenium",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/51\">",
"       51",
"      </a>",
"      ]. Although initial analyses showed patterns of increased incidence, no statistically significant occupational risk factors were found after adjustment for known risk factors such as nevus count and sun exposure.",
"     </li>",
"     <li>",
"      Dietary &mdash; Studies addressing the role of dietary factors (eg, antioxidants, retinoids, vitamin C, and vitamin E) have not shown a consistent impact on the incidence of melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. A case control study has suggested that diets rich in vitamin D and carotenoids and low in alcohol may be associated with a reduced risk for melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=see_link&amp;anchor=H932779#H932779\">",
"       \"Primary prevention of melanoma\", section on 'Dietary vitamin D'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Smoking &mdash; Although skin changes may be related to smoking, smoking has not been found to be an independent risk factor for melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Oral contraceptives and postmenopausal hormone therapy &mdash; Multiple studies have assessed the risk of melanoma associated with oral contraceptives (OCPs), with some finding an elevated risk, particularly with prolonged use. However, two meta-analyses of observational studies showed no evidence for an increased risk of melanoma with the use of OCPs [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/56,57\">",
"       56,57",
"      </a>",
"      ]. Post-hoc analysis of the Women&rsquo;s Health Initiative trials on postmenopausal hormone therapy (HT) found no increased risk of melanoma with HT [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/58\">",
"       58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link&amp;anchor=H26#H26\">",
"       \"Risks and side effects associated with estrogen-progestin contraceptives\", section on 'Melanoma'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endometriosis &mdash; A prospective epidemiologic study has shown a statistically significant increase of melanoma in women with endometriosis (relative risk 1.6) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/59\">",
"       59",
"      </a>",
"      ]. Smaller retrospective studies have observed a similar relationship [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Parkinson disease &mdash; Parkinson disease has been associated with an increased risk for melanoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/61-64\">",
"       61-64",
"      </a>",
"      ]. An epidemiologic study involving more than 14,000 patients with Parkinson disease found a statistically significant increase in the incidence of melanoma in this population compared to the general population (standard incidence ratio 1.95, 95% CI 2.4-2.6) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/61\">",
"       61",
"      </a>",
"      ]. Although early case reports mentioned levodopa (a common therapy for Parkinson disease) as a potential etiologic factor [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/65\">",
"       65",
"      </a>",
"      ], an increased risk for melanoma precedes the diagnosis and treatment of the neurologic disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/62\">",
"       62",
"      </a>",
"      ]. In addition, a systematic review and a subsequent case-control study found no association between melanoma and this drug [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/65,66\">",
"       65,66",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tumor necrosis factor (TNF)-inhibitors &mdash; A connection between TNF-alpha inhibitors and melanoma has been proposed in a few case reports [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/67-70\">",
"       67-70",
"      </a>",
"      ]. However, additional studies are necessary to determine whether treatment with TNF-inhibitors influences the risk for melanoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TYPICAL NEVI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although some moles are precursors to cutaneous melanoma, they are more often markers of increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/71\">",
"     71",
"    </a>",
"    ]. Benign nevi are usually &le;5 mm in diameter, and can be raised or flat with a round shape and uniform color. Most of these nevi occur in photo-exposed areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Quantity of nevi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in Australian children show that the number of nevi are linked to cumulative sun exposure during the first decade of life [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/72\">",
"     72",
"    </a>",
"    ]. As with melanoma itself, children living closer to the equator have greater nevus counts than those at more distant latitudes.",
"   </p>",
"   <p>",
"    The relative risk (RR) of melanoma that is associated with high total nevus counts ranges from 1.6 to 64 with a dose-response effect based upon the number of nevi present (including routine junctional, compound, and dermal nevi) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/25,26,73,74\">",
"     25,26,73,74",
"    </a>",
"    ]. The number most often cited as the cut-off for increased melanoma risk is 50 to 100 nevi, which is associated with a RR of 5 to 17 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/21,75\">",
"     21,75",
"    </a>",
"    ]. However, a more recent meta-analysis of observational studies found that increased risk may be present in individuals with more than 25 nevi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/76\">",
"     76",
"    </a>",
"    ]. In this study, 42 percent of melanoma cases were attributable to having &ge;25 typical nevi (population attributable fraction (PAF) = 0.15). Lower nevus counts were less strongly associated with melanoma (PAF for 0-10 nevi = 0.04, PAF for 11-24 nevi = 0.07).",
"   </p>",
"   <p>",
"    The \"divergent pathway\" model describes the theory that individuals with the propensity to develop fewer melanocytic nevi require greater sun exposure to promote the development of melanoma, and tend to develop melanoma on chronically sun exposed sites (eg, head or neck) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. Conversely, individuals with large numbers of nevi may require less solar stimulation to drive the development of melanoma and are prone to develop melanoma in sites where large numbers of nevi are found, such as the back. This \"divergent pathway\" model suggests that melanomas on different sites of the body may occur via different mechanisms.",
"   </p>",
"   <p>",
"    Studies have supported a strong association of high nevus counts with melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/78,80-82\">",
"     78,80-82",
"    </a>",
"    ]. A meta-analysis of 24 observational studies found that high nevus counts were more strongly associated with the development of melanoma on the legs or trunk (RR = 1.79, 95% CI 1.56-2.06 and 1.67, 1.45-1.92, respectively), when compared to anatomical sites associated with chronic sun exposure, such as the head or arms (RR = 1.42,1.23-1.64 and 1.60, 1.39-1.83, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/82\">",
"     82",
"    </a>",
"    ]. In addition, a pooled analysis of ten case control studies (2406 female melanoma patients and 3119 female controls) identified a statistically significant trend indicating an association of increasing numbers of nevi with melanoma on the trunk and limbs, but not with melanoma of the head and neck [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/80\">",
"     80",
"    </a>",
"    ]. The relative risks for melanoma in women with high numbers of nevi compared with women with no nevi were reported as highest for melanoma on the trunk (OR = 4.6; 95% CI 2.7-7.6) and limbs (OR = 3.4, 1.5-7.9), followed by the head and neck (OR = 2.0, 0.9-4.5).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Risk of malignant transformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The annual rate of transformation of any single mole into melanoma ranges from 0.0005 percent for men and women younger than 40 years, to 0.003 percent for men older than 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/83\">",
"     83",
"    </a>",
"    ]. In addition, the lifetime risk for any selected mole to transform into melanoma by age 80 years is approximately 0.03 percent for men and 0.009 percent for women [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/83,84\">",
"     83,84",
"    </a>",
"    ]. Previous studies suggest a significantly higher prevalence of benign nevi in adult renal transplant recipients, an additional risk factor for the increased incidence of melanoma in this population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/85\">",
"     85",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link\">",
"     \"Development of malignancy following solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Congenital nevi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital melanocytic nevi (CMN) are classically defined as melanocytic nevi present at birth or within the first few months of life. These occur in 1 to 2 percent of newborn infants, and large or giant CMN occur in approximately 1 of 20,000 births.",
"   </p>",
"   <p>",
"    The clinical features, complications, and management of CMN are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7447?source=see_link\">",
"     \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     HISTORY OF MELANOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A personal history of melanoma is associated with a higher risk of developing a second primary cutaneous melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/86-92\">",
"     86-92",
"    </a>",
"    ]. Although the risk is highest in the first year after the initial diagnosis, there is a progressive increase over time, and estimates of the risk of developing a second melanoma have ranged from 2 to 11 percent at five years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/87,89\">",
"     87,89",
"    </a>",
"    ]. Among patients who have had two primary cutaneous melanomas, up to 30 percent may have a third melanoma within five years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient characteristics may influence the probability of developing additional lesions. For individuals with a history of both dysplastic nevi and cutaneous melanoma, the risk of a second primary lesion is greater than for those with a sporadic cutaneous melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/89\">",
"     89",
"    </a>",
"    ]. Age and lesion site also may be markers for increased risk. In one population-based study, patients who were less than 30 years of age at the time of the initial diagnosis or who had a history of melanoma on the head or neck had a greater risk for developing a second primary lesion than other melanoma survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/86\">",
"     86",
"    </a>",
"    ]. High nevus counts, strong family history of melanoma (melanoma in more than one first degree relative), and melanoma type also affect the risk of developing additional primary melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/93\">",
"     93",
"    </a>",
"    ]. In a cohort of 1083 melanoma patients who were followed for more than 16 years, the hazard ratios (HR) for developing a second primary melanoma were highest for patients with high nevus counts (HR 2.91, 95% CI 1.94&ndash;4.35), strong family history of melanoma (HR 2.12, 95% CI 1.34&ndash;3.36), and for patients having lentigo maligna melanoma (HR 1.80, 95% CI 1.05&ndash;3.07) or nodular melanoma as the first primary melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data obtained from the SEER registry from 1973 to 2006 indicate that compared with first melanomas, second melanomas tend to be thinner at the time of diagnosis (78 versus 70 percent &lt;1 mm in depth) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/86\">",
"     86",
"    </a>",
"    ]. The authors of this study speculated that increased clinical surveillance",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    patient awareness following the initial diagnosis may have contributed to this finding. A general trend towards earlier detection of melanoma also may have been a factor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/94\">",
"     94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link\">",
"     \"Screening and early detection of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ROLE OF GENETIC BACKGROUND IN RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of melanomas are familial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/95\">",
"     95",
"    </a>",
"    ]. Among subjects from melanoma families, defined as kindreds in which melanoma occurred in two or more blood relatives, the likelihood of developing melanoma is even greater among those family members who have dysplastic nevi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/96\">",
"     96",
"    </a>",
"    ]. In a subset of these kindreds, the apparent familial pattern of inheritance may be attributable to clustering of sporadic cases in families who share common heavy sun exposure and susceptible skin type, making genetic analysis and risk stratification more challenging. This concept is substantiated by studies in which CDKN2A mutation status, sun exposure, and prevalence of",
"    <span class=\"nowrap\">",
"     dysplastic/benign",
"    </span>",
"    nevi influence melanoma risk in families unselected for family history as well as melanoma-prone families [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There appears to be considerable genetic heterogeneity among different families, suggesting that multiple genes contribute to melanoma predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/97\">",
"     97",
"    </a>",
"    ]. Molecular defects in both tumor suppressor genes and oncogenes have been linked to familial melanoma. The major gene resides on chromosome 9p and encodes the tumor suppressor gene CDKN2A, also called p16INK4A or MTS1 (multiple tumor suppressor-1). These issues are described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=see_link\">",
"     \"Inherited susceptibility to melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ATYPICAL NEVI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of atypical nevi in the general population, and their relevance to the development of melanoma is controversial. For many years, the term \"melanocytic dysplasia\" with its implication of a precancerous condition, made the management of patients with dysplastic moles difficult. In a 1992 consensus conference, the term dysplastic nevus was abandoned in favor of \"atypical nevus\" in the hope of avoiding confusing terminology [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/98\">",
"     98",
"    </a>",
"    ]. Defined histologic criteria were established, and expert pathologists agreed upon a new reporting system. Despite these attempts to unify nomenclature for microscopically dysplastic nevi through the NIH Consensus Conference, wide variation in terminology still persists [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atypical nevi may evolve from a normal appearing nevus, or be dysplastic from their first appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/100\">",
"     100",
"    </a>",
"    ]. There are several clinical features that characterize a nevus as atypical [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/101\">",
"     101",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They tend to be larger than common nevi, usually 4 to 12 mm in diameter [",
"      <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/73\">",
"       73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Color variability is important; shades of tan or brown and pink without black are present in most cases (",
"      <a class=\"graphic graphic_picture graphicRef68734 \" href=\"UTD.htm?22/39/23153\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Although the overall border of an atypical nevus is fairly regular with some notching, the outer edges are characteristically ill-defined or fuzzy (",
"      <a class=\"graphic graphic_picture graphicRef78689 \" href=\"UTD.htm?30/46/31471\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence or absence of these atypical features correlates, albeit imperfectly, with the presence or absence of histologic dysplasia. In a series of 101 patients with a history of sporadic melanoma in whom the most clinically atypical nevus was removed, the likelihood of histologic dysplasia was 7, 23, and 62 percent in cases with one, two, or three atypical features, respectively (ie, diameter &ge;5 mm, ill",
"    <span class=\"nowrap\">",
"     defined/irregular",
"    </span>",
"    border, color variability) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a few major clinical variants of atypical nevi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/73,98\">",
"     73,98",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fried egg atypical nevus, a dermal nevus surrounded by a macular oval",
"     </li>",
"     <li>",
"      The cobblestoned or pebbled surface type with a rim of macular pigmentation",
"     </li>",
"     <li>",
"      The notched, uniformly colored macule, which is a common pattern",
"     </li>",
"     <li>",
"      The two toned asymmetrical patch with a fuzzy border",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although atypical nevi share some of the clinical characteristics of melanoma, they are generally stable and asymptomatic. Progression to melanoma is most often manifested as a new focal area of deep pigmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lesions with marked asymmetry in both axes, excessive color variation (more than two colors), markedly irregular border throughout, areas of regression (gray, pink, white), or a history of change or symptoms should be considered for surgical excision and histological examination.",
"   </p>",
"   <p>",
"    Lesions with moderate to severe melanocytic atypia should be conservatively excised with 2 to 3 mm margins to prevent recurrences. Lesions with mild atypia can be followed clinically for recurrences if incompletely excised. However, several physicians do recommend complete excisions with histological clearance for all dysplastic nevi to minimize the likelihood of recurrence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link\">",
"     \"Screening and early detection of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical importance of atypical nevi lies in their association with melanoma risk [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/25,96,103-106\">",
"     25,96,103-106",
"    </a>",
"    ]. Individuals with atypical nevi have an associated 3- to 20-fold elevated risk of developing malignant melanoma compared to the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/76,105,107\">",
"     76,105,107",
"    </a>",
"    ]. Of all melanomas, approximately 10 to 20 percent arise within atypical nevi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of atypical nevi present on the patient's skin is a powerful predictor of melanoma risk anywhere in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/25\">",
"     25",
"    </a>",
"    ]. However, the risk of melanoma developing within an atypical nevus is relatively low given their relatively high prevalence in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atypical nevi are part of a complex melanoma risk factor profile that includes total nevus burden, family history, personal history, and sun exposure history [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/73,107\">",
"     73,107",
"    </a>",
"    ]. The presence of more than 10 atypical nevi markedly elevates a patient's risk (approximately 12- to 20-fold). If fewer than 10 atypical nevi are present there is a lesser increase in risk that appears to vary with sun exposure. In one report, the odds ratio for melanoma in individuals with three or more atypical nevi was 4.6 in Australia (high sun exposure) compared to 52 in England (lower sun exposure) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Germline mutations in the CDKN2A, ARF, CDK4 and somatic mutations in the PTEN, BRAF, and NRAS genes have been associated with melanoma and acquired nevi. However, a link between the presence of multiple atypical nevi and these specific mutations has not been established [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     FAMMM syndrome and atypical mole syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some familial cases of melanoma occur in the setting of the familial atypical multiple mole and melanoma (FAMMM) syndrome and the atypical mole syndrome (AMS).",
"   </p>",
"   <p>",
"    The FAMMM syndrome was originally described in families showing concordance for malignant melanoma and a cutaneous phenotype characterized by multiple large moles of variable size and color (reddish-brown to bright red) with pigmentary leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/109,110\">",
"     109,110",
"    </a>",
"    ]. Their lifetime cumulative incidence of melanoma approached 100 percent.",
"   </p>",
"   <p>",
"    A family history of cutaneous melanoma in at least two first degree relatives, and younger age at diagnosis are important components of this syndrome. The median age at diagnosis in one series of 23 kindreds was 33 years, well below that in patients with sporadic melanomas; this difference is due in part to the increased rate of p16 mutations associated with this syndrome, in addition to an increased surveillance of subjects from affected families [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/111\">",
"     111",
"    </a>",
"    ]. Affected subjects may have over 100 nevi, with lesions that are predominantly truncal and in sun exposed areas. However, they can also occur on the scalp, feet, and genitalia.",
"   </p>",
"   <p>",
"    The magnitude of the relative risk for melanoma in patients with FAMMM is difficult to estimate. A classification scheme (Kraemer's categories) has been developed to classify patients with atypical nevi according to their risk for melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/104\">",
"     104",
"    </a>",
"    ]. Category D2 includes those individuals with atypical nevi and a family history of atypical nevi and melanoma, a similar phenotype as those with FAMMM [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/104\">",
"     104",
"    </a>",
"    ]. The estimated cumulative RR for melanoma in this group of patients ranges from 127 to 444 at approximately five years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/103,104\">",
"     103,104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The atypical mole syndrome (AMS), also sometimes called the dysplastic nevus syndrome (DNS), refers to patients who have 50 to 100 or more nevi, at least one of which is &ge;8 mm in diameter, and at least one with atypical features, without family of personal or family history of melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The genetic aspects of melanoma are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=see_link\">",
"     \"Inherited susceptibility to melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     NONMELANOMA SKIN CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals who have had basal cell or squamous cell skin carcinomas appear to have not only an increased risk of developing melanoma, but also an increased risk of dying from it [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/112,113\">",
"     112,113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;De novo melanoma occurs with increased frequency in immunosuppressed patients, such as organ transplant recipients. Among patients with melanoma treated before transplantation, recurrences are frequent (19 percent in one series), and usually occur within five years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/114\">",
"     114",
"    </a>",
"    ]. Waiting at least five years between the treatment of melanoma and transplantation may reduce the risk of recurrent disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/115\">",
"     115",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link&amp;anchor=H52#H52\">",
"     \"Development of malignancy following solid organ transplantation\", section on 'Transplantation in patients with preexisting malignancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Melanoma may also be more prevalent in individuals who are HIV positive. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link&amp;anchor=H1560506382#H1560506382\">",
"     \"HIV infection and malignancy: Management considerations\", section on 'Skin cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanoma in situ has been reported in two patients during long-term therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    , an antifungal drug that has been associated with cutaneous photosensitivity and squamous cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/116\">",
"     116",
"    </a>",
"    ]. Additional studies are necessary to determine whether there is an association between melanoma and this drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43034015\">",
"    <span class=\"h1\">",
"     RISK ASSESSMENT IN INDIVIDUAL PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several tools have been developed to help clinicians and patients identify risk factors for melanoma. These tools are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link&amp;anchor=H18038601#H18038601\">",
"     \"Screening and early detection of melanoma\", section on 'Tools for ascertaining risk'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF HIGH RISK PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary emphasis in patient management should be on prevention and early detection when the disease is curable. Identification of high-risk patients for routine screening is essential. Significant risk factors include a family or personal history of melanoma, more than 10 atypical nevi, increased numbers of normal nevi (greater than 50), blistering sunburns in the first two decades of life, older age, male sex, and light hair color. A statistical model using these factors has been constructed based upon three large cohorts of patients with melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/117\">",
"     117",
"    </a>",
"    ]. Individuals in the highest decile of risk had more than a threefold increase in the incidence of melanoma compared to those in the lowest decile. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=see_link&amp;anchor=H15#H15\">",
"     \"Screening and early detection of melanoma\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Sun protection",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV-B radiation causes sunburn and appears to cause the most acute DNA damage. However, the flux of UV-A radiation that reaches the earth's surface is 10- to 100-fold greater and also contributes to the pathogenesis of melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/118\">",
"     118",
"    </a>",
"    ]. Sun protection to prevent melanoma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=see_link&amp;anchor=H5#H5\">",
"     \"Primary prevention of melanoma\", section on 'Sun protection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Changing pigmented lesion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subjective or objective change in a pigmented lesion markedly increases (up to 500-fold) the likelihood that a lesion is a melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/24,73\">",
"     24,73",
"    </a>",
"    ]. The change can be symptomatic (eg, pruritus, bleeding) or observed (eg, change in color, size, shape). Since benign lesions are thought to be stable or demonstrating a very slow change in pigmentation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    size overtime (years), any lesion that is reported to have changed should be taken seriously. Similar considerations apply to any lesion that develops above age 40, an age at which acquisition of pigmented lesions is unusual. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/20/16713?source=see_link&amp;anchor=H81531898#H81531898\">",
"     \"Skin examination and clinical features of melanoma\", section on 'Management of patients with suspicious skin lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     FAMMM syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the familial atypical multiple mole and melanoma (FAMMM) syndrome need careful monitoring and education. It is recommended that high-risk family members undergo a baseline, complete examination, including the scalp, with removal of any lesions that are clinically suggestive of melanoma. Children in these families should have their first skin examination by age 10, or sooner if clinically indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These patients are generally followed at three to six month intervals with total body examination by a dermatologist [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/96,103,104,107,119,120\">",
"     96,103,104,107,119,120",
"    </a>",
"    ]. At these visits, a history of new lesions or a change in preexisting ones should be elicited. The total body should be examined including scalp, breasts, and genitalia. Specialized pigmented lesion clinics and some dermatology practices have incorporated the use of total body digital photography. In addition, close up 1:1 photographs or dermoscopy images can be taken of selected lesions and followed serially [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periods of accelerated mole change and new mole development may occur, sometimes (although not always) during times of hormonal change such as puberty or pregnancy. Surveillance should be heightened during such times [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surveillance for pancreatic cancer is warranted only in families with CDKN2A mutations in which at least one pancreatic cancer case has been observed. These individuals should be referred to a gastroenterologist. Similarly, brain tumors should be sought only in families in which such cancers appear to be part of the clinical syndrome. Family members should be instructed to examine their own skin monthly aided by copies of their skin photographs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=see_link&amp;anchor=H3#H3\">",
"     \"Inherited susceptibility to melanoma\", section on 'CDKN2A gene'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pigmented lesions of concern (by dermatoscopic or regular examination), or those which the patient or a family member feels are changing significantly, should be promptly but conservatively excised. Superficial shave biopsy should be avoided in this clinical setting to minimize the risk of incomplete removal of the lesion and subsequent problems in histologic evaluation, and interpretation of recurrent pigmentation at a prior biopsy site.",
"   </p>",
"   <p>",
"    An important adjunct to management of these individuals includes education about the ABCDEs of melanoma: asymmetry, border irregularities, color variegation (ie, different colors within the same region), diameter greater than 6 mm, and enlargement. Since the majority of the nevi in this group of patients are atypical, the identification of a changing mole is particularly relevant in the monitoring of these individuals. If possible, the patient's significant other or a family member should be involved in screening the affected areas not accessible by self-skin examination.",
"   </p>",
"   <p>",
"    Patients with atypical nevi may have an increased incidence of ocular melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/122\">",
"     122",
"    </a>",
"    ]. Whether patients with FAMMM or DNS should undergo regular ophthalmologic evaluation remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/101,123,124\">",
"     101,123,124",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/59/8122?source=see_link\">",
"     \"Ocular melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The identification of specific genetic mutations that increase the risk of melanoma in certain families has led to the development of tests to screen for these mutations. The use of these tests is controversial. The issue of genetic testing for melanoma susceptibility is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=see_link&amp;anchor=H19#H19\">",
"     \"Inherited susceptibility to melanoma\", section on 'Genetic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     High mole burden",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with multiple atypical nevi",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    multiple benign nevi should undergo a surveillance regimen similar to those with FAMMM. Management may be difficult when there are more than 50 nevi and photographs are useful, if feasible.",
"   </p>",
"   <p>",
"    Total body or regional photographs are helpful in the evaluation of these complex phenotypes. Several studies support the use of this technique and suggest a higher sensitivity and specificity in detecting changes in size, shape, and color of pigmented and nonpigmented lesions that can lead to early detection of malignant melanomas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/125-127\">",
"     125-127",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-risk lesions can be examined with a dermatoscope, which is a hand-held instrument that magnifies pigmented lesions approximately 10-fold. Using an algorithm that emphasizes pattern analysis and a history of change, a well-trained observer can be fairly accurate in diagnosing melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/53/24410/abstract/101,128,129\">",
"     101,128,129",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Videomicroscopy is now available in academic centers and commercially. This technique uses a video microscope linked to a computer that generates a melanomagram. The melanomagram predicts the likelihood of an individual pigmented lesion being a melanoma. However, all lesions clinically suspected of being a melanoma should be surgically excised and not overruled on the basis of videomicroscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H74824828\">",
"    <span class=\"h2\">",
"     Melanoma chemoprevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanoma chemoprevention is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=see_link&amp;anchor=H49280705#H49280705\">",
"     \"Primary prevention of melanoma\", section on 'Chemoprevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/20/23874?source=see_link\">",
"       \"Patient information: Sunburn (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/30/18913?source=see_link\">",
"       \"Patient information: Sunburn (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=see_link\">",
"       \"Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/8/39042?source=see_link\">",
"       \"Patient information: Melanoma treatment; advanced or metastatic melanoma (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1907897\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of melanoma has increased rapidly over the years. In the United States, melanoma is the fifth most common cancer in men and the seventh most common cancer in women. (See",
"      <a class=\"local\" href=\"#H5112797\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evidence suggests that ultraviolet light is a major risk factor for melanoma. Although ultraviolet B radiation plays a greater role in the development of melanoma, exposure to ultraviolet A radiation (including tanning beds and psoralen-ultraviolet A radiation [PUVA] therapy) also appears to be a risk factor. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Sun exposure and UV radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Melanoma tends to be associated with a history of intense, intermittent sun exposure, and most frequently occurs on areas that are exposed to the sun sporadically, such as the back in men and legs in women. However, chronic sun exposure may contribute to the development of melanoma on other sites, such as the head and neck. A history of multiple severe sunburns in childhood also is associated with increased melanoma risk. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Timing and pattern of sun exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The results of several studies have implicated tanning beds as a risk factor for melanoma. In 2009, the World Health Organization classified ultraviolet light emitted from tanning beds as a human carcinogen. Ultraviolet A therapy with high doses of psoralens (PUVA) has also been identified as a risk factor for melanoma. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Tanning beds'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'PUVA therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patient-specific factors influence the risk for melanoma. High numbers of typical nevi, the presence of atypical nevi, a personal history of melanoma, and genetic factors can increase risk. Patients with the familial atypical multiple mole and melanoma (FAMMM) syndrome have a risk of melanoma much greater than that of the general population. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients at high-risk for melanoma should be counseled about sun protection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=see_link&amp;anchor=H5#H5\">",
"       \"Primary prevention of melanoma\", section on 'Sun protection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nevi that change in appearance or symptoms or new nevi after the age for 40 should be examined closely for the possibility of malignancy. Photography may be useful for monitoring patients with multiple atypical or numerous typical nevi. Dermoscopy and videomicroscopy are additional techniques that have been used to monitor nevi. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Management of high risk patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/1\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/2\">",
"      Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/3\">",
"      Jemal A, Saraiya M, Patel P, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol 2011; 65:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/4\">",
"      Swetter SM, Boldrick JC, Jung SY, et al. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005; 125:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/5\">",
"      Cockburn M, Swetter SM, Peng D, et al. Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? J Am Acad Dermatol 2008; 59:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/6\">",
"      Howlader N, Ries LA, Stinchcomb DG, Edwards BK. The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst 2009; 101:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/7\">",
"      Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/8\">",
"      Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/9\">",
"      Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/10\">",
"      MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009; 20 Suppl 6:vi1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/11\">",
"      Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005; 331:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/12\">",
"      Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996; 132:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/13\">",
"      Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol 2009; 129:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/14\">",
"      Waldmann A, Nolte S, Weinstock MA, et al. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer 2012; 106:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/15\">",
"      Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23:4735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/16\">",
"      Lange JR, Palis BE, Chang DC, et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol 2007; 25:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/17\">",
"      Jafarian F, Powell J, Kokta V, et al. Malignant melanoma in childhood and adolescence: report of 13 cases. J Am Acad Dermatol 2005; 53:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/18\">",
"      Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health 2005; 29:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/19\">",
"      Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol 2011; 65:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/20\">",
"      Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66:201.",
"     </a>",
"    </li>",
"    <li>",
"     Tsao HK, Pehamberger H, Sober AJ. Precursor lesions and markers for increased risk of melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Cutaneous Melanoma (Ed), Quality Medical Publishing Inc, St. Louis 1998. p.65.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/22\">",
"      Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006; 166:1907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/23\">",
"      Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 2005; 141:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/24\">",
"      Rhodes AR, Weinstock MA, Fitzpatrick TB, et al. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 1987; 258:3146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/25\">",
"      Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997; 277:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/26\">",
"      Veier&oslash;d MB, Weiderpass E, Th&ouml;rn M, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003; 95:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/27\">",
"      Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 1999; 340:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/28\">",
"      Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 1997; 73:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/29\">",
"      Bulliard JL, Cox B, Elwood JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 1994; 5:234.",
"     </a>",
"    </li>",
"    <li>",
"     Devesa SS, Grauman DJ, Blot WJ, et al. Atlas of cancer mortality in the United States 1950&ndash;1994, NIH Pub No. 99&ndash;4564, Bethesda, MD 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/31\">",
"      Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev 2000; 9:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/32\">",
"      Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005; 97:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/33\">",
"      Kricker A, Armstrong BK, Goumas C, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007; 18:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/34\">",
"      Buckel TB, Goldstein AM, Fraser MC, et al. Recent tanning bed use: a risk factor for melanoma. Arch Dermatol 2006; 142:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/35\">",
"      Nelemans PJ, Groenendal H, Kiemeney LA, et al. Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 1993; 101:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/36\">",
"      Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study. Int J Cancer 1985; 35:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/37\">",
"      Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/38\">",
"      Whiteman DC, Stickley M, Watt P, et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006; 24:3172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/39\">",
"      Cooke KR, Fraser J. Migration and death from malignant melanoma. Int J Cancer 1985; 36:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/40\">",
"      Holman CD, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/41\">",
"      Young AR. The sunburn cell. Photodermatol 1987; 4:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/42\">",
"      Centers for Disease Control and Prevention (CDC). Use of indoor tanning devices by adults--United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/43\">",
"      El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens--part D: radiation. Lancet Oncol 2009; 10:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/44\">",
"      International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 2007; 120:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/45\">",
"      Lazovich D, Vogel RI, Berwick M, et al. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010; 19:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/46\">",
"      Cust AE, Armstrong BK, Goumas C, et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer 2011; 128:2425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/47\">",
"      Veier&oslash;d MB, Adami HO, Lund E, et al. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev 2010; 19:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/48\">",
"      Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol 1990; 108:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/49\">",
"      Vajdic CM, Kricker A, Giblin M, et al. Artificial ultraviolet radiation and ocular melanoma in Australia. Int J Cancer 2004; 112:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/50\">",
"      Stern RS, PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/51\">",
"      Ward EM, Burnett CA, Ruder A, Davis-King K. Industries and cancer. Cancer Causes Control 1997; 8:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/52\">",
"      Hercberg S, Ezzedine K, Guinot C, et al. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 2007; 137:2098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/53\">",
"      Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol 2009; 145:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/54\">",
"      Millen AE, Tucker MA, Hartge P, et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/55\">",
"      Merimsky O, Inbar M. Cigarette smoking and skin cancer. Clin Dermatol 1998; 16:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/56\">",
"      Pfahlberg A, Hassan K, Wille L, et al. Systematic review of case-control studies: oral contraceptives show no effect on melanoma risk. Public Health Rev 1997; 25:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/57\">",
"      Gandini S, Iodice S, Koomen E, et al. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer 2011; 47:2607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/58\">",
"      Tang JY, Spaunhurst KM, Chlebowski RT, et al. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. J Natl Cancer Inst 2011; 103:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/59\">",
"      Kvaskoff M, Mesrine S, Fournier A, et al. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women. Arch Intern Med 2007; 167:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/60\">",
"      Somigliana E, Vigano' P, Parazzini F, et al. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol 2006; 101:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/61\">",
"      Olsen JH, Friis S, Frederiksen K, et al. Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer 2005; 92:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/62\">",
"      Olsen JH, Friis S, Frederiksen K. Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 2006; 17:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/63\">",
"      Bertoni JM, Arlette JP, Fernandez HH, et al. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol 2010; 67:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/64\">",
"      Inzelberg R, Israeli-Korn SD. The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers. J Neural Transm 2009; 116:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/65\">",
"      Zanetti R, Loria D, Rosso S. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma Res 2006; 16:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/66\">",
"      Olsen JH, Tangerud K, Wermuth L, et al. Treatment with levodopa and risk for malignant melanoma. Mov Disord 2007; 22:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/67\">",
"      Kowalzick L, Eickenscheidt L, Komar M, Schaarschmidt E. [Long term treatment of psoriasis with TNF-alpha antagonists. Occurrence of malignant melanoma]. Hautarzt 2009; 60:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/68\">",
"      Khan I, Rahman L, McKenna DB. Primary cutaneous melanoma: a complication of infliximab treatment? Clin Exp Dermatol 2009; 34:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/69\">",
"      Fulchiero GJ Jr, Salvaggio H, Drabick JJ, et al. Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies. J Am Acad Dermatol 2007; 56:S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/70\">",
"      Manganoni AM, Zane C, Pavoni L, et al. Cutaneous melanoma in patients in treatment with biological therapy: review of the literature and case report. Dermatol Online J 2011; 17:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/71\">",
"      Purdue MP, From L, Armstrong BK, et al. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005; 14:2015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/72\">",
"      Harrison SL, MacLennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young Australian children. Lancet 1994; 344:1529.",
"     </a>",
"    </li>",
"    <li>",
"     Barnhill RL. Melanocytic proliferations with architectural disorder and cytologic atypia (melanocytic dysplasia and atypical nevi). In: Pathology of Melanocytic Nevi and Melanoma, Barnhill RL (Ed), Butterworth-Heinemann, Newton, MA 1995. p.169.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/74\">",
"      Chaudru V, Chompret A, Bressac-de Paillerets B, et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 2004; 96:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/75\">",
"      Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/76\">",
"      Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma. Cancer Prev Res (Phila) 2010; 3:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/77\">",
"      Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 1998; 77:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/78\">",
"      Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/79\">",
"      Rivers JK. Is there more than one road to melanoma? Lancet 2004; 363:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/80\">",
"      Olsen CM, Zens MS, Stukel TA, et al. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 2009; 124:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/81\">",
"      Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 2005; 14:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/82\">",
"      Caini S, Gandini S, Sera F, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009; 45:3054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/83\">",
"      Tsao H, Bevona C, Goggins W, Quinn T. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol 2003; 139:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/84\">",
"      Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/85\">",
"      Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997; 194:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/86\">",
"      Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010; 146:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/87\">",
"      Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003; 97:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/88\">",
"      DiFronzo LA, Wanek LA, Elashoff R, Morton DL. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999; 6:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/89\">",
"      Greene MH. The genetics of hereditary melanoma and nevi. 1998 update. Cancer 1999; 86:2464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/90\">",
"      Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005; 294:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/91\">",
"      Levi F, Randimbison L, Te VC, La Vecchia C. High constant incidence rates of second cutaneous melanomas. Int J Cancer 2005; 117:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/92\">",
"      Spanogle JP, Clarke CA, Aroner S, Swetter SM. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. J Am Acad Dermatol 2010; 62:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/93\">",
"      Siskind V, Hughes MC, Palmer JM, et al. Nevi, family history, and fair skin increase the risk of second primary melanoma. J Invest Dermatol 2011; 131:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/94\">",
"      Baumert J, Schmidt M, Giehl KA, et al. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype. Melanoma Res 2009; 19:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/95\">",
"      Rivers JK. Melanoma. Lancet 1996; 347:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/96\">",
"      Carey WP Jr, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994; 74:3118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/97\">",
"      Goldstein AM, Dracopoli NC, Engelstein M, et al. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet 1994; 54:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/98\">",
"      Elder DE, Clark WH Jr, Elenitsas R, et al. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993; 10:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/99\">",
"      Shapiro M, Chren MM, Levy RM, et al. Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004; 31:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/100\">",
"      Clark WH Jr, Elder DE, Guerry D 4th, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/101\">",
"      Naeyaert JM, Brochez L. Clinical practice. Dysplastic nevi. N Engl J Med 2003; 349:2233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/102\">",
"      Grob JJ, Andrac L, Romano MH, et al. Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol 1988; 118:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/103\">",
"      Tucker MA, Fraser MC, Goldstein AM, et al. Risk of melanoma and other cancers in melanoma-prone families. J Invest Dermatol 1993; 100:350S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/104\">",
"      MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993; 341:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/105\">",
"      Kang S, Barnhill RL, Mihm MC Jr, et al. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol 1994; 130:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/106\">",
"      Bataille V, Grulich A, Sasieni P, et al. The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 1998; 77:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/107\">",
"      Halpern AC, Guerry D 4th, Elder DE, et al. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993; 100:346S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/108\">",
"      Celebi JT, Ward KM, Wanner M, et al. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome. Clin Exp Dermatol 2005; 30:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/109\">",
"      Lynch HT, Frichot BC 3rd, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978; 15:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/110\">",
"      Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol 1978; 114:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/111\">",
"      Goldstein AM, Fraser MC, Clark WH Jr, Tucker MA. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi. J Natl Cancer Inst 1994; 86:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/112\">",
"      Marghoob AA, Slade J, Salopek TG, et al. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995; 75:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/113\">",
"      Kahn HS, Tatham LM, Patel AV, et al. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 1998; 280:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/114\">",
"      Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/115\">",
"      Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/116\">",
"      Miller DD, Cowen EW, Nguyen JC, et al. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity. Arch Dermatol 2010; 146:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/117\">",
"      Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005; 23:2669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/118\">",
"      Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/119\">",
"      Masri GD, Clark WH Jr, Guerry D 4th, et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990; 22:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/120\">",
"      Wang SQ, Kopf AW, Koenig K, et al. Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy. J Am Acad Dermatol 2004; 50:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/121\">",
"      Haenssle HA, Korpas B, Hansen-Hagge C, et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol 2010; 146:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/122\">",
"      Weis E, Shah CP, Lajous M, et al. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis. Ophthalmology 2009; 116:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/123\">",
"      Seregard S, af Trampe E, M&aring;nsson-Brahme E, et al. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology 1995; 102:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/124\">",
"      Rodriguez-Sains RS. Ocular findings in patients with dysplastic nevus syndrome. An update. Dermatol Clin 1991; 9:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/125\">",
"      Banky JP, Kelly JW, English DR, et al. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005; 141:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/126\">",
"      Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol 2002; 20:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/127\">",
"      Tiersten AD, Grin CM, Kopf AW, et al. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol 1991; 17:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/128\">",
"      Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/53/24410/abstract/129\">",
"      Carli P, Mannone F, De Giorgi V, et al. The problem of false-positive diagnosis in melanoma screening: the impact of dermoscopy. Melanoma Res 2003; 13:179.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4844 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-DF5911362B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24410=[""].join("\n");
var outline_f23_53_24410=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1907897\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5112797\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5112804\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5112823\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sun exposure and UV radiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - UV-A versus UV-B irradiation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Timing and pattern of sun exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Tanning beds",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - PUVA therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TYPICAL NEVI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Quantity of nevi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Risk of malignant transformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Congenital nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      HISTORY OF MELANOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ROLE OF GENETIC BACKGROUND IN RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ATYPICAL NEVI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FAMMM syndrome and atypical mole syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      NONMELANOMA SKIN CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      IMMUNOSUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43034015\">",
"      RISK ASSESSMENT IN INDIVIDUAL PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      MANAGEMENT OF HIGH RISK PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Sun protection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Changing pigmented lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      FAMMM syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      High mole burden",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H74824828\">",
"      Melanoma chemoprevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1907897\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/4844\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/4844|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/39/23153\" title=\"picture 1\">",
"      Atypical nevi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/46/31471\" title=\"picture 2\">",
"      Dysplastic nevus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/17/7447?source=related_link\">",
"      Congenital melanocytic nevi and speckled lentiginous nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=related_link\">",
"      Inherited susceptibility to melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/59/8122?source=related_link\">",
"      Ocular melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/8/39042?source=related_link\">",
"      Patient information: Melanoma treatment; advanced or metastatic melanoma (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=related_link\">",
"      Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/30/18913?source=related_link\">",
"      Patient information: Sunburn (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/20/23874?source=related_link\">",
"      Patient information: Sunburn (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18073?source=related_link\">",
"      Primary prevention of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/16/16650?source=related_link\">",
"      Screening and early detection of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/20/16713?source=related_link\">",
"      Skin examination and clinical features of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40042?source=related_link\">",
"      Treatment of psoriasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_53_24411="PCP risk factors";
var content_f23_53_24411=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for Pneumocystis pneumonia in patients without HIV infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Glucocorticoid use in patients with another cause of immunocompromise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other immunosuppressive drugs:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antirejection medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Purine analogs (eg, fludarabine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Infliximab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Defects in cell-mediated immunity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cancer (particularly hematologic malignancy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematopoietic stem cell transplantation (HCT; especially allogeneic HCT)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solid organ transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment for rejection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treatment for inflammatory conditions (eg, granulomatosis with polyangiitis [Wegener's])",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe malnutrition (especially protein malnutrition)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary immunodeficiencies (particularly severe combined immunodeficiency)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prematurity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24411=[""].join("\n");
var outline_f23_53_24411=null;
var title_f23_53_24412="ACC AHA AVR in chronic AR";
var content_f23_53_24412=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA Guideline Summary: Indications for aortic valve replacement or repair (AVR) in chronic aortic regurgitation (AR)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or",
"general agreement that aortic valve replacement or repair (AVR) is",
"indicated in patients with chronic AR in the following settings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Symptomatic patients with severe chronic AR, irrespective of left ventricular ejection fraction (LVEF).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; If the presence of symptoms in patients with severe chronic AR is equivocal, the development of symptoms during an exercise test.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Asymptomatic patients with severe chronic AR and an LVEF &le;50 percent at rest.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Patients with severe chronic AR who undergo coronary artery bypass graft surgery (CABG) or surgery on the aorta or other heart valves.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence",
"or opinion is in favor of the usefulness of AVR in patients with",
"chronic AR in the following setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        &bull;&nbsp; Asymptomatic patients with severe chronic AR and a normal LVEF (LVEF &gt;50 percent) who have severe left ventricular dilatation (end-diastolic dimension &gt;75 mm or end-systolic dimension &gt;55 mm). Lower threshold values can be considered for patients of small stature.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The weight of evidence",
"or opinion is less well established for the usefulness of AVR in",
"patients with chronic AR in the following settings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Patients with moderate chronic AR who undergo CABG or surgery on the ascending aorta.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        &bull;&nbsp; Asymptomatic patients with severe chronic AR and an LVEF &gt;50 percent in whom the end-diastolic dimension is &gt;70 mm or the end-systolic dimension is &gt;50 mm, and there is evidence of progressive left ventricular dilatation, declining exercise tolerance, or an abnormal hemodynamic response to exercise.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence and/or",
"general agreement that AVR is NOT indicated in patients with chronic AR",
"in the following setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"1\">",
"        &bull;&nbsp; Asymptomatic patients with mild, moderate, or severe chronic AR and an LVEF &gt;50 percent at rest in whom the degree of left ventricular dilatation is not moderate or severe (end-diastolic dimension &lt;70 mm or end-systolic dimension &lt;50 mm).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24412=[""].join("\n");
var outline_f23_53_24412=null;
var title_f23_53_24413="X-linked adrenoleukodystrophy A";
var content_f23_53_24413=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70311&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    X-linked adrenoleukodystrophy (X-ALD) phenotypes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Phenotypes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total ALD, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptoms/ signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Age at present- ation (years)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mis- diagnosed as",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diag- nostic test",
"       </td>",
"       <td class=\"subtitle1\">",
"        Follow- up tests",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recom- mended therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"8\">",
"        Males",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asymptomatic (MRI normal)",
"       </td>",
"       <td>",
"        Increasing",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        0 to &ge;10",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        <p>",
"         VLCFA in relatives of X-ALD patients",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td>",
"        Monitor MRI and adrenal function; family screening",
"       </td>",
"       <td>",
"        Lorenzo's oil, adrenal HRT if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asymptomatic (MRI abnormal)",
"       </td>",
"       <td>",
"        Increasing",
"       </td>",
"       <td>",
"        None (cognition normal)",
"       </td>",
"       <td>",
"        2 to &ge;10",
"       </td>",
"       <td>",
"        Other white matter disorders",
"       </td>",
"       <td>",
"        <p>",
"         VLCFA, brain MRI",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td>",
"        Neurological and neuro- psychological testing, adrenal function",
"       </td>",
"       <td>",
"        HSCT, adrenal HRT if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Addison disease only (MRI normal)",
"       </td>",
"       <td>",
"        20 (decreases with age)",
"       </td>",
"       <td>",
"        Primary adrenocortical insufficiency, normal neurology, MRI normal",
"       </td>",
"       <td>",
"        0 to &ge;10",
"       </td>",
"       <td>",
"        Other causes of Addison disease",
"       </td>",
"       <td>",
"        <p>",
"         VLCFA",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td>",
"        Monitor MRI, neurological and neuro- psychological testing",
"       </td>",
"       <td>",
"        Lorenzo's oil, adrenal HRT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Addison disease only (MRI abnormal)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        Primary adrenocortical insufficiency",
"       </td>",
"       <td>",
"        0 to &ge;10",
"       </td>",
"       <td>",
"        Other causes of Addison disease",
"       </td>",
"       <td>",
"        <p>",
"         VLCFA, brain MRI",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td>",
"        Neurological and neuro- psychological testing, MRI",
"       </td>",
"       <td>",
"        HSCT, adrenal HRT if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Cerebral (mild) without AMN*",
"       </td>",
"       <td rowspan=\"3\">",
"        45",
"       </td>",
"       <td rowspan=\"3\">",
"        Behavior changes, school failure, dementia, audiovisual",
"       </td>",
"       <td>",
"        3-10 (common)",
"       </td>",
"       <td rowspan=\"3\">",
"        ADHD, psychological disorder, Asperger syndrome, autism",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         VLCFA, brain MRI",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td rowspan=\"3\">",
"        Neurological and neuro- psychological testing, family screening, adrenal function",
"       </td>",
"       <td rowspan=\"3\">",
"        HSCT, adrenal HRT if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11-21 (inter- mediate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        21 (rare)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cerebral (severe) without AMN*",
"       </td>",
"       <td>",
"        2-3",
"       </td>",
"       <td>",
"        Dementia, psychoses, paralysis, epilepsy, loss of vision, loss of speech, bulbar palsy",
"       </td>",
"       <td>",
"        5 to adulthood",
"       </td>",
"       <td>",
"        Other neuro- degenerative diseases, brain tumor, psychosis, epilepsy",
"       </td>",
"       <td>",
"        <p>",
"         VLCFA, brain MRI",
"        </p>",
"        <p>",
"         Confirm with DNA",
"        </p>",
"       </td>",
"       <td>",
"        Adrenal function, neurological and neuro- psychological testing, family screening",
"       </td>",
"       <td>",
"        Adrenal HRT if indicated, general support",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Percentages listed above vary by age group, as the asymptomatic and Addison disease groups decline with age while the ALD and AMN groups increase.",
"    <div class=\"footnotes\">",
"     ADHD: attention-deficit/hyperactivity disorder; ALS: amyotrophic lateral sclerosis; DNA: ABCD1 mutation analysis; AMN: adrenomyeloneuropathy; EEG: electroencephalogram; HRT: hormone replacement therapy; HSCT: hematopoietic stem cell transplant; MRI: magnetic resonance imaging; MTS: magnetization transfer MRI cervical cord; SSEP: somatosensory evoked potential; VLCFA: very long chain fatty acids assay in plasma.",
"     <br>",
"      * For a description of the distinction between the mild and severe cerebral forms, see: Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 2005; 294:3131. Copyright &copy; 2005 American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24413=[""].join("\n");
var outline_f23_53_24413=null;
var title_f23_53_24414="African Burkitt lymphoma";
var content_f23_53_24414=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F52625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F52625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Burkitt lymphoma (African/endemic)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 245px; height: 248px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A large tumor involving the left side of the jaw is apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Warnke RA, Weiss LM, Chan JK, et al. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24414=[""].join("\n");
var outline_f23_53_24414=null;
var title_f23_53_24415="Lichen scrofulosorum";
var content_f23_53_24415=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen scrofulosorum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple follicular lichenoid papules are present on the trunk.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. M Ramam, New Delhi.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_53_24415=[""].join("\n");
var outline_f23_53_24415=null;
